Processing 00000000.tx.1: 17-Estradiol Decreases Nitric Oxide Synthase II Synthesis in Vascular Smooth Muscle Cells1 Valeria Zancan, Sabrina Santagati, Chiara Bolego, Elisabetta Vegeto, Adriana Maggi and Lina Puglisi Institute of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy Address all correspondence and requests for reprints to: Lina Puglisi, Institute of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "Decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "Nitric Oxide Synthase II Synthesis in Vascular Smooth Muscle Cells1 Valeria Zancan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1157570:nitric oxide synthesis [Molecular Function]
   736   C0220781:synthesis [Biologic Function]
   736   C1883254:Synthesis [Activity]

Phrase: "Sabrina Santagati,"

Phrase: "Chiara Bolego,"

Phrase: "Elisabetta Vegeto,"

Phrase: "Adriana Maggi"

Phrase: "and"

Phrase: "Lina Puglisi Institute of Pharmacological Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "University of Milan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Via Balzaretti 9,"

Phrase: "20133 Milan,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Lina Puglisi,"

Phrase: "Institute of Pharmacological Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "University of Milan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Via Balzaretti 9,"

Phrase: "20133 Milan,"

Phrase: "Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]
Processing 00000000.tx.2: E-mail: Lina.

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Lina."
Processing 00000000.tx.3: Puglisi{at}unimi.it  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Several studies have provided evidence for a direct effect of 17-estradiol on vessel wall via interaction with the constitutively expressed nitric oxide synthase (NOS) by endothelium. 

Phrase: "Puglisi{at}unimi."

Phrase: "it  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "provided evidence for a direct effect of 17-estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "on vessel wall"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "via interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with the constitutively"

Phrase: "expressed"

Phrase: "nitric oxide synthase (NOS) by endothelium."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   864   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   864   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   864   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   862   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.4: The aim of the present study was to investigate the effect of 17-estradiol on inducible NOS (NOS II) in primary culture of smooth muscle cells (SMC) from rat aorta. 

Phrase: "The aim of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1947946:Aim [Idea or Concept]
   753   C2948600:Aim [Pharmacologic Substance]
   753   C3540471:AIM [Gene or Genome]
   753   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of 17-estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on inducible NOS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NOS II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "in primary culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0010453:Culture [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "of smooth muscle cells (SMC)"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "from rat aorta."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   861   C0003483:Aorta [Body Part, Organ, or Organ Component]
   861   C1278934:Aorta [Body Part, Organ, or Organ Component]
Processing 00000000.tx.5: We here prove that 17-estradiol decreases the content and activity of NOS II in SMC. 

Phrase: "We here"

Phrase: "prove"

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "activity of NOS II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1151383:nitric-oxide synthase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   716   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in SMC."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.6: This effect appears to be the consequence of ER activation, because: 1) ER and ER are expressed in rat aorta SMC grown in culture; 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the consequence of ER activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "because"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "expressed in rat aorta SMC"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   778   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   748   C0003483:Aorta [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1278934:Aorta [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "grown in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.7: 2) low concentrations of hormone modulate NOS II activity; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "low concentrations of hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "NOS II activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   933   C1151383:nitric-oxide synthase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.8: 3) the specific ER antagonist ICI182,780 completely blocks 17-estradiol effect. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "the specific ER antagonist ICI182,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C2267020:Estrogen Receptor Antagonist [Pharmacologic Substance]

Phrase: "780 completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "17-estradiol effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.9: On the other hand, progesterone is deprived of any effect on NOS II content or activity, proving the specificity of 17-estradiol effect. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "is"

Phrase: "deprived of any effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on NOS II content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "proving"

Phrase: "the specificity of 17-estradiol effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.10: In addition, we show that 17-estradiol can counteract the increase in NOS II activity following cytokine treatment. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "can"

Phrase: "counteract"

Phrase: "the increase in NOS II activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cytokine treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.11: The observation could indicate a novel mechanism for the protective effects exerted by these hormones in cardiovascular diseases and atherosclerosis in particular.  

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "could"

Phrase: "indicate"

Phrase: "a novel mechanism for the protective effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "exerted by these hormones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015264:Exerted [Organism Function]
   770   C0019932:Hormones [Hormone]

Phrase: "in cardiovascular diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular Diseases [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "atherosclerosis in particular."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0004153:Atherosclerosis [Disease or Syndrome]
   718 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.12: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  THE LOW INCIDENCE of vascular events in premenopausal women as well as the rapid increase in angina, myocardial infarction, and stroke in women following menopause are well recognized. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "THE LOW INCIDENCE of vascular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "in premenopausal women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "as well as"

Phrase: "the rapid increase in angina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "myocardial infarction,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]

Phrase: "and"

Phrase: "stroke in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038454:Stroke [Disease or Syndrome]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "are"

Phrase: "well recognized."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]
Processing 00000000.tx.13: Several explanations for these epidemiological observations have been proposed (1, 2). 

Phrase: "Several explanations for these epidemiological observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanations [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: It is well documented that women on estrogen replacement therapy have a 4050% reduction in the risk of coronary artery disease (3, 4). 

Phrase: "It"

Phrase: "is"

Phrase: "well documented"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "that women on estrogen replacement therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0043210:Women [Population Group]

Phrase: "have"

Phrase: "a 4050% reduction in the risk of coronary artery disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1137094:Risk Reduction [Individual Behavior]
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.15: While a substantial portion of this effect has been attributed to estrogen-mediated increase in high-density lipoprotein-cholesterol (5, 6, 7), the alterations in lipid profile account for only about 50% of the cardiovascular benefit observed in estrogen-treated women, suggesting that other mechanisms may be involved (8). 

Phrase: "While"

Phrase: "a substantial portion of this effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to estrogen-mediated increase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0442805:Increase [Functional Concept]
   760   C2936882:Estrogen [Pharmacologic Substance]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "in high-density lipoprotein-cholesterol"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0023822:High Density Lipoprotein Cholesterol [Biologically Active Substance,Lipid]
   923   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   902   C1522133:high cholesterol [Finding]
   861   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "the alterations in lipid profile account"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "for only about 50%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "of the cardiovascular benefit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814225:Benefit [Quantitative Concept]

Phrase: "observed in estrogen-treated women,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0043210:Women [Population Group]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C2936882:Estrogen [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.16: Several studies provide evidence for a direct effect of estrogen on the vessel wall mediated through specific intracellular receptors acting as ligand-activated transcription factors (9, 10). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for a direct effect of estrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "on the vessel wall"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "mediated through specific intracellular receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1552740:specific [Intellectual Product]

Phrase: "acting as ligand-activated transcription factors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0023688:Ligand [Chemical]
   753   C0040649:Transcription [Genetic Function]
   753   C1879547:Activated [Activity]
   719   C0079613:ACT [Therapeutic or Preventive Procedure]
   719 E C1515877:Activate [Functional Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.17: A number of animal studies have demonstrated 17-estradiol specific binding to vascular cells, supporting the hypothesis that vascular tissue is estrogen sensitive (11, 12). 

Phrase: "A number of animal studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "17-estradiol specific binding to vascular cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205369:Specific [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1552740:specific [Intellectual Product]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that vascular tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   972   C1511228:Blood Vessel Tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.18: Recently, the presence of a functional estrogen receptor- (ER) has been demonstrated both in vascular smooth muscle and in endothelial cells (13, 14, 15). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the presence of a functional estrogen receptor- (ER)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "both in vascular smooth muscle"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0026844:Muscle, Smooth, Vascular [Tissue]
   806   C1267092:Muscle, Smooth [Tissue]
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0026845:Muscle [Tissue]
   760   C0205357:Smooth [Qualitative Concept]
   760   C0238767:Both [Spatial Concept]
   760   C1558950:VASCULAR [Finding]
   760   C1706086:Both [Qualitative Concept]
   760   C1801960:Vascular [Qualitative Concept]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and in endothelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(13,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.19: It is now known that the two ERs so far described (named ER and ER) (16) are hormone-dependent transcription factors that modulate the transcription of selected genes by binding to consensus regulatory sequences, referred to as EREs (estrogen responsive elements) located in the promoter of the target genes (17). 

Phrase: "It"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that"

Phrase: "the two ERs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704489:ERS [Clinical Attribute]
   861   C2931783:ERS [Disease or Syndrome]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(named ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "(16"

Phrase: ")"

Phrase: "are"

Phrase: "hormone-dependent transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the transcription of selected genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "by binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to consensus regulatory sequences,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   913   C0079160:Sequences, Consensus [Nucleotide Sequence]
   867   C0314642:Regulatory sequence [Nucleotide Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as EREs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883351:To [Qualitative Concept]

Phrase: "(estrogen responsive elements"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0013879:Elements [Element, Ion, or Isotope]
   827   C0205342:Responsive [Functional Concept]
   793 E C1705248:Element [Conceptual Entity]
   755 E C2371924:Responsivity [Mental Process]

Phrase: ")"

Phrase: "located in the promoter of the target genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C1332838:Target Gene [Gene or Genome]
   750   C0314621:Promoter gene [Gene or Genome]
   744   C0017337:Genes [Gene or Genome]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1521840:Target [Functional Concept]
   744   C2986546:TARGET [Diagnostic Procedure]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.20: Recent studies indicate that 17-estradiol up-regulates nitric oxide synthase (NOS) III messenger RNA (mRNA) in cultured endothelial cells (18, 19, 20), and this may represent a possible mechanism for the protective role of estrogens on the vessel wall. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "III messenger RNA (mRNA) in cultured endothelial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0335218:Messenger [Professional or Occupational Group]

Phrase: "(18,"

Phrase: "19,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a possible mechanism for the protective role of estrogens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "on the vessel wall."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.21: NO is the most potent endogenous vasodilator. 

Phrase: "NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1298908:no [Idea or Concept]
  1000   C1549444:No [Idea or Concept]

Phrase: "is"

Phrase: "the most potent endogenous vasodilator."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042402:Vasodilator [Pharmacologic Substance]
   812   C3537240:Vasodilator [Pharmacologic Substance]
Processing 00000000.tx.22: In the vessel wall, its synthesis is regulated by two major types of NOS: a constitutive form (cNOS, NOS III), normally expressed in endothelial cells, and an inducible form (iNOS, NOS II), mostly expressed in smooth muscle cells after exposure to inflammatory stimuli (21, 22, 23). 

Phrase: "In the vessel wall,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "its synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "regulated by two major types of NOS"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   807   C1864814:REGULATED BY NITRIC OXIDE [Gene or Genome]
   790   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0205164:Major [Qualitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0332307:Types [Qualitative Concept]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C2986642:oxide [Chemical Viewed Functionally]
   708 E C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "a constitutive form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(cNOS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0669365:CNOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "NOS III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "normally"

Phrase: "expressed in endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "an inducible form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(iNOS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0669372:INOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:INOS [Gene or Genome]
  1000   C1968833:INOS [Gene or Genome]
  1000   C3539722:iNOS [Gene or Genome]

Phrase: "NOS II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "expressed in smooth muscle cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1135918:Smooth Muscle Cells [Cell]
   806   C0596981:Muscle Cells [Cell]
   806   C1267092:Muscle, Smooth [Tissue]
   760   C0007634:Cells [Cell]
   760   C0026845:Muscle [Tissue]
   760   C0205357:Smooth [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to inflammatory stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "(21,"

Phrase: "22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.23: Excessive NOS II production induced by proinflammatory stimuli (cytokines and lipopolysaccharides) has been associated with atherosclerosis, whereas reduced NO synthesis due to impaired NOS III activity may be responsible for hypertension and vascular pathologies (21, 24). 

Phrase: "Excessive NOS II production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0033268:production [Occupational Activity]
   734   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induced by proinflammatory stimuli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induced [Functional Concept]
   770   C0234402:Stimuli [Phenomenon or Process]

Phrase: "(cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "lipopolysaccharides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023810:Lipopolysaccharides [Lipid]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "associated with atherosclerosis,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0004153:Atherosclerosis [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "whereas"

Phrase: "reduced NO synthesis due to impaired NOS III activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   772   C1157570:nitric oxide synthesis [Molecular Function]
   738   C0220781:synthesis [Biologic Function]
   738   C1883254:Synthesis [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for hypertension"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "vascular pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0030664:Pathologies [Biomedical Occupation or Discipline]
   827 E C0205469:pathology [Functional Concept]
   827 E C0677042:pathology [Pathologic Function]
   777 E C1521733:Pathologic [Functional Concept]

Phrase: "(21,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.24: The aim of the present study was to investigate the effects of 17-estradiol and progesterone on NOS II protein content and activity in primary cultures of smooth muscle cells from rat aorta. 

Phrase: "The aim of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1947946:Aim [Idea or Concept]
   753   C2948600:Aim [Pharmacologic Substance]
   753   C3540471:AIM [Gene or Genome]
   753   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effects of 17-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "progesterone on NOS II protein content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   744   C2757070:Progesterone [Pharmacologic Substance]

Phrase: "and"

Phrase: "activity in primary cultures of smooth muscle cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   731   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "from rat aorta."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   861   C0003483:Aorta [Body Part, Organ, or Organ Component]
   861   C1278934:Aorta [Body Part, Organ, or Organ Component]
Processing 00000000.tx.25: The results here presented demonstrate that 17-estradiol, but not progesterone, decreases NOS II protein content and activity, suggesting that estrogens may contribute to an anti-inflammatory action in these cells.  

Phrase: "The results here"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "that 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "but"

Phrase: "not progesterone,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   861   C2757070:Progesterone [Pharmacologic Substance]
   805 E C0010094:Corpus luteum hormone [Hormone]
   805 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   805 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   805 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "NOS II protein content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0423896:Content [Mental Process]
   799   C0456205:Content [Conceptual Entity]
   734   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "contribute to an anti-inflammatory action"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0003209:Anti-inflammatory [Pharmacologic Substance]
   790   C1515999:Anti-inflammatory [Qualitative Concept]
   753   C0333348:Inflammatory [Functional Concept]
   753   C0441472:Action [Functional Concept]
   753   C1880177:Contribute [Activity]
   753   C3266814:Action [Activity]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.26: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Materials The steroids 17-estradiol, 17-estradiol and progesterone, as well as the antiestrogen tamoxifen were obtained from Sigma Chemical Co. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "The steroids 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "progesterone,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "as well as"

Phrase: "the antiestrogen tamoxifen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   805 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Sigma Chemical Co."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0220806:Chemical [Chemical]
   760   C1301820:Obtained [Functional Concept]
   760   C1719918:Sigma [Intellectual Product]
   760   C3272558:Chemical [Intellectual Product]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.27: (Milano, Italy). 

Phrase: "(Milano,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")."
Processing 00000000.tx.28: The antiestrogen ICI 182,780 was kindly provided by Zeneca Pharmaceuticals (Macclesfield, UK). 

Phrase: "The antiestrogen ICI 182,780"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]
   812   C0014930:Antiestrogen [Pharmacologic Substance]
   812   C0752229:Antiestrogen [Pharmacologic Substance]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Zeneca Pharmaceuticals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   770   C1254351:Pharmaceuticals [Pharmacologic Substance]
   770   C1999230:Provided [Activity]
   737 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: "(Macclesfield,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.29: Antirabbit NOS II polyclonal antibody was purchased from Transduction Laboratories, Inc. 

Phrase: "Antirabbit NOS II polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   710   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "purchased from Transduction Laboratories,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1160185:transduction [Organism Function]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.30: (Lexington, KY). 

Phrase: "(Lexington,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.31: Oligodeoxynucleotides were synthesized by Pharmacia Biotech (Cambridge, UK). 

Phrase: "Oligodeoxynucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028948:Oligodeoxynucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized by Pharmacia Biotech"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0331955:Pharmacia [Health Care Related Organization]
   770   C1883254:Synthesized [Activity]

Phrase: "(Cambridge,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.32: Cell cultures Smooth muscle cells (SMC) were obtained from the intimal-medial layers of aorta of male Sprague Dawley rats (Charles River Laboratories, Inc., Calco, Italy) (200250 g), according to Ross (25). 

Phrase: "Cell cultures Smooth muscle cells"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C1135918:Smooth Muscle Cells [Cell]
   875   C0596981:cell muscle [Cell]
           Muscle Cells
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "(SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from the intimal-medial layers of aorta of male Sprague Dawley rats"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   766   C0034715:Rats, Sprague-Dawley [Mammal]
   750   C2699239:Sprague-Dawley [Mammal]
   735   C0003483:Aorta [Body Part, Organ, or Organ Component]
   735   C0024554:Male [Finding]
   735   C0034693:rats [Mammal]
   735   C0034721:Rats [Mammal]
   735   C0086582:male [Population Group]
   735   C0205098:Medial [Spatial Concept]
   735   C0934502:layers [Body Part, Organ, or Organ Component]
   735   C1278934:Aorta [Body Part, Organ, or Organ Component]
   735   C1301820:Obtained [Functional Concept]
   735   C1706180:Male [Qualitative Concept]
   735   C1706428:Male [Qualitative Concept]
   735   C1706429:Male [Organism Attribute]
   732   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   702 E C1522408:Layer [Qualitative Concept]
   702 E C1561599:Layer [Intellectual Product]
   702 E C1706701:Obtain [Activity]

Phrase: "(Charles River Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "Calco,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: "(200250 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "according to Ross"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.33: Cells were grown in monolayers in medium 199 (M199) supplemented with 10% (vol/vol) FCS, 50 U/ml penicillin, 50 g/ml streptomycin, 2 mM glutamine, and 2.2 g/liter NaHCO3 (referred to as "M199 + FCS") and were incubated at 37 C in a humidified atmosphere with 5% CO2. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in monolayers in medium 199 (M199)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C0872351:monolayers [Clinical Drug]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "(vol/vol) FCS,"

Phrase: "50 U/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "50 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "2 mM glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "2.2 g/liter NaHCO3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as ""M199 + FCS"""

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "incubated at 37 C in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "a humidified atmosphere with 5% CO2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004178:Atmosphere [Natural Phenomenon or Process]
   753   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.34: SMC were characterized for growth and morphology and by immunostaining with monoclonal antibodies recognizing the actin -isoform typically expressed by SMC (26). 

Phrase: "SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "characterized for growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C1880022:Characterized [Activity]
   790   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and by immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "with monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "the actin -isoform typically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "expressed by SMC"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1135918:Smooth Muscle Cells [Cell]
   806   C0596981:Muscle Cells [Cell]
   806   C1267092:Muscle, Smooth [Tissue]
   760   C0007634:Cells [Cell]
   760   C0026845:Muscle [Tissue]
   760   C0205357:Smooth [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.35: For the experiments here described, cells grown at passages 26 were seeded into either 60-mm Petri dishes (2 x 105 cells/dish) or 24-well plates (5 x 104 cells/well). 

Phrase: "For the experiments here"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown at passages 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0439799:Passage [Spatial Concept]

Phrase: "were"

Phrase: "seeded into either 60-mm Petri dishes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   745   C1322960:Petri dish [Medical Device]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "(2 x 105 cells/dish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2347576:Cells/dish [Quantitative Concept]
   804   C0020498:DISH [Disease or Syndrome]

Phrase: ")"

Phrase: "or"

Phrase: "24-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(5 x 104 cells/well"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C2347578:Cells/well [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C0205170:Well [Qualitative Concept]
   804   C0439084:>5 [Quantitative Concept]
   804   C0728893:+5 [Quantitative Concept]
   804   C3146287:Well [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.36: Cells were grown in M199 + FCS for 48 h; 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "in M199 + FCS for 48 h"

Phrase: ";"
Processing 00000000.tx.37: then, the medium was replaced with phenol red-free M199 with 10% FCS (wM199 + FCS). 

Phrase: "then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with phenol red-free M199"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   778   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C1541709:Red free [Qualitative Concept]
   748   C0009458:Medium [Intellectual Product]
   748   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0332296:free [Functional Concept]
   748   C0332575:Red [Finding]
   748   C0439536:Medium [Quantitative Concept]
   748   C0559956:Replaced [Functional Concept]
   748   C1260956:Red [Qualitative Concept]
   748   C1299987:replaced [Functional Concept]
   748   C1705217:Medium [Substance]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C3244283:medium [Intellectual Product]
   714 E C1554078:Replace [Idea or Concept]

Phrase: "with 10% FCS"

Phrase: "(wM199 + FCS"

Phrase: ")."
Processing 00000000.tx.38: At 1624 h before the hormonal treatment, cells were incubated with phenol red-free M199 without serum (wM199). 

Phrase: "At 1624 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before the hormonal treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with phenol red-free M199"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   778   C1541709:Red free [Qualitative Concept]
   748   C0009458:Medium [Intellectual Product]
   748   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0332296:free [Functional Concept]
   748   C0332575:Red [Finding]
   748   C0439536:Medium [Quantitative Concept]
   748   C1260956:Red [Qualitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1705217:Medium [Substance]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C3244283:medium [Intellectual Product]

Phrase: "without serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "(wM199"

Phrase: ")."
Processing 00000000.tx.39: Pharmacological agents were added for 24 h, as specified in each figure legend. 

Phrase: "Pharmacological agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   933   C1254351:Pharmacologic Agent [Pharmacologic Substance]
           Agent
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1521826:Agent [Intellectual Product]

Phrase: "were"

Phrase: "added for 24 h,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "as"

Phrase: "specified in each figure legend."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205369:Specified [Qualitative Concept]
   760   C2729544:Legend [Pharmacologic Substance]
   726 E C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.40: Typically, the treatments were done with confluent cells. 

Phrase: "Typically,"

Phrase: "the treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "done with confluent cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0205200:Confluent [Qualitative Concept]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.41: RT-PCR Total cell RNA was isolated from rat uterus, used as a positive control for ER mRNA expression, and VSMC cells with the Bio/RNA-X Cell kit (Bio/Gene, Kimbolton Cambridge, UK), using 1 ml of RNA-X reagent for 1 g of tissue or for 10 x 106 cells. 

Phrase: "RT-PCR Total cell RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0035681:polymerase rna [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from rat uterus,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1882904:Rat Uterus [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0042149:Uterus [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C1269032:Uterus [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "used as a positive control"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for ER mRNA expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0597360:receptor expression [Genetic Function]
   840   C0040649:RNA Expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "VSMC cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with the Bio/RNA-X Cell kit (Bio/Gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C1861886:CELL Gene [Gene or Genome]
   829   C0920288:KIT Gene [Gene or Genome]
   829   C1416655:KIT gene [Gene or Genome]
   795   C0017337:Gene [Gene or Genome]

Phrase: "Kimbolton Cambridge,"

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1 ml of RNA-X reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "for 1 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "or for 10 x 106 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.42: 1 g of total RNA was denatured at 68 C with 10 pmol oligo-d(T)1218 (Perkin Elmer, Milan, Italy) and reverse-transcribed using MuMLV reverse transcriptase (HT Biotechnology Ltd., Cambridge, UK) as previously described (27). 

Phrase: "1 g of total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "denatured at 68 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0450387:68 [Intellectual Product]

Phrase: "with 10 pmol oligo-d(T"

Phrase: ")"

Phrase: "1218"

Phrase: "(Perkin Elmer,"

Phrase: "Milan,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "-"

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MuMLV reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1555029:Reverse [Idea or Concept]
   827   C2257077:transcriptase [Genetic Function]

Phrase: "(HT Biotechnology Ltd.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1136140:LTD [Organ or Tissue Function]

Phrase: "Cambridge,"

Phrase: "UK"

Phrase: ")"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.43: One-tenth of the complementary DNA (cDNA) reaction was amplified containing 2.5 U of DynaZyme-DNA polymerase (Finenzyme OY, Espo, Finland), the buffer provided by Finenzyme, 0.2 mM dNTP and 100 pmol PCR primers in 100 l final volume. 

Phrase: "One-tenth of the complementary DNA (cDNA) reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205444:Tenth [Quantitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "amplified"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2.5 U of DynaZyme-DNA polymerase"

Phrase: "(Finenzyme OY,"

Phrase: "Espo,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "the buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "provided by Finenzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]

Phrase: "0.2 mM dNTP"

Phrase: "and"

Phrase: "100 pmol PCR primers in 100 l final volume."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.44: Amplification of ER- mRNA was obtained as previously described (28). 

Phrase: "Amplification of ER-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0335218:Messenger [Professional or Occupational Group]

Phrase: "was"

Phrase: "obtained as previously"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.45: Briefly, the region of 254 bp, from nucleotide (nt) 530 to nt 784, was amplified using as primers ER-1a (5'-AGCGTGTCGCCGAGTCCG-3') and ER-1 (5'-AGCACAGTAGCGAGTCTC-3'). 

Phrase: "Briefly,"

Phrase: "the region of 254 bp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "from nucleotide (nt) 530"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to nt 784,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified"

Phrase: "using as primers ER-"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   781   C0239301:ESTROGEN USE [Finding]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1524063:Using [Functional Concept]
   760   C2936882:Estrogen [Pharmacologic Substance]
   726 E C0042153:use [Functional Concept]
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "(5'-AGCGTGTCGCCGAGTCCG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "ER-1"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1121711:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR 1 [Gene or Genome]
           ESTROGEN RECEPTOR
  1000   C1521863:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
           Estrogen Receptor
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(5'-AGCACAGTAGCGAGTCTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.46: After denaturing at 94 C for 5 min, PCR amplification was performed for 30 cycles (94 C for 15 sec, 48 C for 20 sec, and 72 C for 30 sec) followed by a final extension step (72 C for 3 min). 

Phrase: "After denaturing"

Phrase: "at 94 C"

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "PCR amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed for 30 cycles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   737   C1511572:Cycle [Temporal Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(94 C for 15 sec,"

Phrase: "48 C for 20 sec,"

Phrase: "and"

Phrase: "72 C for 30 sec)"

Phrase: "followed by a final extension step"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0205088:Final [Temporal Concept]
   753   C0231448:Extension [Functional Concept]
   753   C1261552:Step [Conceptual Entity]
   753   C1546485:Final [Idea or Concept]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C1880641:Extension [Conceptual Entity]
   753   C2825408:Step [Manufactured Object]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(72 C for 3 min)."
Processing 00000000.tx.47: The duration and temperature of the PCR cycles were experimentally optimized to fall into the exponential phase of the amplification (28). 

Phrase: "The duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "and"

Phrase: "temperature of the PCR cycles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]

Phrase: "were"

Phrase: "experimentally"

Phrase: "optimized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fall into the exponential phase of the amplification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0085639:Fall [Finding]
   744   C0205390:Phase [Temporal Concept]
   744   C0238715:Fall [Temporal Concept]
   744   C1517480:Amplification [Molecular Biology Research Technique]
   744   C1521871:Amplification [Phenomenon or Process]
   744   C1552645:exponential [Qualitative Concept]
   744   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.48: At the 30th cycle, the reaction was terminated by addition of 50 l of DNA dye (50% glycerol and 0.25% wt/vol xylene cyanol). 

Phrase: "At the 30th cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by addition of 50 l of DNA dye"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1173589:dye 50 [Organic Chemical]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   742   C1553404:terminated [Idea or Concept]
   742   C1883712:Addition [Functional Concept]
   742   C2348570:Terminated [Functional Concept]

Phrase: "(50% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.25% wt/vol xylene cyanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0377925:xylene cyanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.49: Fifteen microliters of the incubation mixture were then loaded onto a 3% agarose gel, together with the appropriate molecular weight markers. 

Phrase: "Fifteen microliters of the incubation mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "loaded onto a 3% agarose gel,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1382104:Gel [Substance]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "together with the appropriate molecular weight markers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0005516:molecular markers [Clinical Attribute]
           Marker
Processing 00000000.tx.50: The bands corresponding to the amplified DNA were then visualized by ethidium bromide staining. 

Phrase: "The bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "corresponding to the amplified DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "visualized by ethidium bromide staining."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   760   C0006222:Bromide [Inorganic Chemical]
   760   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.51: For amplification of the rat ER-, a region of 262 bp, from nt 39 to nt 301, was amplified by primers ER-1 (5'-TTCCCGGCAGCACCAGTAACC-3') and ER-1 (5'-TCCCTCTTTGCGTTTGGACTA-3'). 

Phrase: "For amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of the rat ER-"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C0332285:Of [Spatial Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "a region of 262 bp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "from nt 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to nt 301,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified by primers ER-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1121711:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414461:ESTROGEN RECEPTOR 1 [Gene or Genome]
           ESTROGEN RECEPTOR
   833   C1521863:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
           Estrogen Receptor
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C2936882:Estrogen [Pharmacologic Substance]
   719   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-TTCCCGGCAGCACCAGTAACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "ER-1"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1121711:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR 1 [Gene or Genome]
           ESTROGEN RECEPTOR
  1000   C1521863:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
           Estrogen Receptor
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(5'-TCCCTCTTTGCGTTTGGACTA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.52: After denaturing at 94 C for 5 min, PCR amplification was performed for 40 cycles (94 C for 1 min, 50 C for 1 min, and 72 C for 1 min). 

Phrase: "After denaturing"

Phrase: "at 94 C"

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "PCR amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed for 40 cycles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439509:/40 [Temporal Concept]
   770   C0884358:Performed [Functional Concept]
   737   C1511572:Cycle [Temporal Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(94 C for 1 min,"

Phrase: "50 C for 1 min,"

Phrase: "and"

Phrase: "72 C for 1 min)."
Processing 00000000.tx.53: A subsequent Southern blot and hybridization with a rat ER- probe was done to prove the specificity of the signal. 

Phrase: "A subsequent Southern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0005862:Southern Blot [Molecular Biology Research Technique]
   840   C1148472:Blot, Southern [Laboratory or Test Result]
   804   C1710133:Southern [Spatial Concept]

Phrase: "and"

Phrase: "hybridization with a rat ER-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020202:Hybridisation [Genetic Function]
   753   C1300517:Hybridization [Laboratory Procedure]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "done"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prove"

Phrase: "the specificity of the signal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.54: No amplification product was detected in samples in which either the RT or the cDNA were omitted. 

Phrase: "No amplification product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "detected in samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "in which either"

Phrase: "the RT"

Phrase: "or"

Phrase: "the cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "omitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]
Processing 00000000.tx.55: Southern blot Probe preparation. 

Phrase: "Southern blot Probe preparation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.56: Plasmid pCMV5-ratER- (a gift from Jan-Ake Gustaffson) was used as template for the preparation of nonradioactively labeled DNA probe by means of PCR; 

Phrase: "Plasmid pCMV5-ratER-"

Phrase: "("

Phrase: "a gift from Jan-Ake Gustaffson"

Phrase: ")"

Phrase: "was"

Phrase: "used as template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0728990:TEMPLATE [Medical Device]
   790   C1273517:used [Finding]
   790   C1514575:Template [Conceptual Entity]
   790   C1705542:Template [Idea or Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of nonradioactively labeled DNA probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0012893:DNA probe [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "by means of PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.57: probe corresponded to nt 39 to nt 301 of the rat ER-. 

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "corresponded to nt 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to nt 301"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the rat ER-"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   840   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   840   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C0332285:Of [Spatial Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "."
Processing 00000000.tx.58: PCR reaction mix contained 15 ng plasmid DNA, 0.8 mM ER-1 and ER-1 primers, 0.35 mM Dig-11 dUTP (Boehringer Mannheim, Mannheim, Germany), 0.65 mM dTTP and 1 mM of each dATP, dCTP dGTP, and 2 U Taq DNA polymerase (Perkin Elmer) in 20 l final volume. 

Phrase: "PCR reaction mix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205430:Mix [Functional Concept]
   804   C1421951:MIX [Gene or Genome]
   804   C1720722:Mix [Qualitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "15 ng plasmid DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.8 mM ER-1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   861   C1121711:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
   861   C1414461:ESTROGEN RECEPTOR 1 [Gene or Genome]
           ESTROGEN RECEPTOR
   861   C1521863:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
           Estrogen Receptor
   858   C1418486:MM-1 [Gene or Genome]
   827   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C2936882:Estrogen [Pharmacologic Substance]
   727 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ER-1 primers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1121711:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]
   756   C1414461:ESTROGEN RECEPTOR 1 [Gene or Genome]
   756   C1521863:Estrogen Receptor 1 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "0.35 mM Dig-11 dUTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Boehringer Mannheim,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "0.65 mM dTTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0076582:dTTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "1 mM of each dATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1418486:MM-1 [Gene or Genome]

Phrase: "dCTP dGTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0057430:dGTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "2 U Taq DNA polymerase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   884   C2257065:Taq DNA polymerase [Genetic Function]
   840   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Perkin Elmer"

Phrase: ")"

Phrase: "in 20 l final volume."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.59: PCR reaction profile was as follows: 95 C for 5 min, then 30 cycles at 92 C for 1 min, 50 C for 1 min and 72 C for 1 min. 

Phrase: "PCR reaction profile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1979963:Profile [Laboratory Procedure]
   804   C2003903:Profile [Functional Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "95 C for 5 min,"

Phrase: "then 30 cycles at 92 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1511572:Cycle [Temporal Concept]

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "50 C for 1 min"

Phrase: "and"

Phrase: "72 C for 1 min."
Processing 00000000.tx.60: The 262-bp amplification product was purified on a 1% agarose gel in Tris-acetate EDTA. 

Phrase: "The 262-bp amplification product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "purified on a 1% agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1382104:Gel [Substance]
   753   C1998793:Purified [Functional Concept]

Phrase: "in Tris-acetate EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.61: Electrophoresis, blotting, and hybridization. 

Phrase: "Electrophoresis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "blotting"

Phrase: ","

Phrase: "and"

Phrase: "hybridization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.62: Ten microliters of PCR mix were loaded on 2% agarose gel in Tris-borate EDTA and subjected to electrophoresis performed at 100 V. 

Phrase: "Ten microliters of PCR mix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "loaded on 2% agarose gel"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1706746:Agarose Gel [Research Device]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "in Tris-borate EDTA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0006007:Borate [Chemical Viewed Structurally]
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "performed at 100 V."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.63: The gel was denatured at room temperature for 30 min in 0.5 M NaOH and 1 M NaCl and neutralized in 0.5 M Tris, pH 7.7, 1.5 M NaCl, and 1 mM EDTA for 15 min at room temperature. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "denatured at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in 0.5 M NaOH"

Phrase: "and"

Phrase: "1 M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "neutralized in 0.5 M Tris,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0444499:0/5 [Quantitative Concept]
   783   C1440942:M-5 [Immunologic Factor]
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1.5 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "1 mM EDTA for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.64: DNA was transferred onto nylon membrane (Hybond-N, Amersham Pharmacia Biotech, Milan, Italy) by capillarity blotting o/n in 20 x SSC (3 M NaCl, 0.3 M Na3 citrate2H2O) and then fixed to the membrane by UV irradiation and baking at 80 C for 48 h. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transferred onto nylon membrane"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0025255:Membrane [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C0740034:Nylon [Biomedical or Dental Material]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "(Hybond-N,"

Phrase: "Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Milan,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: "by capillarity blotting o/n"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006903:Capillarity [Natural Phenomenon or Process]
   712 E C0006902:Capillaritis [Disease or Syndrome]

Phrase: "in 20 x SSC (3 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   799   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.3 M Na3 citrate2H2O"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed to the membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025255:Membrane [Tissue]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   770   C2827483:Fixed [Body Substance]

Phrase: "by UV irradiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282930:Irradiation [Natural Phenomenon or Process]
   861   C1522449:irradiation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "baking at 80 C"

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.65: After two subsequent prehybridizations of 1 h at 65 C in "pre 1" solution (250 mM Na-posphate buffer pH 7.2, 7% SDS, 1% BSA and 1 mM EDTA) and "pre2" solution (5 x SSC, 50% formamide, 0.2% SDS, 1% Sarcosyl and Blocking reagent (Boehringer Mannheim) dissolved in 0.01 M Maleic acid, 0.015 M NaCl), heat-denatured Dig-11dUTP-labeled probe was annealed at 42 C o/n and washed at room temperature twice in 5 x SSC for 30 min, once in 1 x SSC containing 0.1% SDS for 30 min and finally, twice in 0.1 x SSC with 0.1% SDS for 15 min. 

Phrase: "After two subsequent prehybridizations"

Phrase: "of 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 65 C in ""pre 1"" solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037633:Solution [Substance]
   799   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(250 mM Na-posphate buffer pH 7.2,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C1882074:pH 7 [Qualitative Concept]
   793   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   793   C1272460:{NA} [Qualitative Concept]

Phrase: "7% SDS,"

Phrase: "1% BSA"

Phrase: "and"

Phrase: "1 mM EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and """

Phrase: "pre2"" solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(5 x SSC,"

Phrase: "50% formamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016568:formamide [Organic Chemical]

Phrase: "0.2% SDS,"

Phrase: "1% Sarcosyl"

Phrase: "and"

Phrase: "Blocking reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Boehringer Mannheim"

Phrase: ")"

Phrase: "dissolved in 0.01 M Maleic acid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0065571:maleic acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   714   C1549535:Dissolve [Functional Concept]

Phrase: "0.015 M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "heat-denatured Dig-11dUTP-labeled probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C0181160:Thermal probe [Medical Device]
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "annealed at 42 C o/n"

Phrase: "and"

Phrase: "washed at room temperature twice"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C1547703:Room [Spatial Concept]
   760   C1548982:Washed [Idea or Concept]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]
   726 E C0441648:Wash [Activity]

Phrase: "in 5 x SSC"

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "once in 1 x SSC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720092:Once [Intellectual Product]
   760   C1948045:Once [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% SDS for 30 min"

Phrase: "and"

Phrase: "finally,"

Phrase: "twice in 0.1 x SSC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]

Phrase: "with 0.1% SDS"

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.66: The subsequent enhanced chemiluminescent reaction was performed as specified by the manufacturers (Boehringer Mannheim). 

Phrase: "The subsequent enhanced chemiluminescent reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "specified by the manufacturers"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205369:Specified [Qualitative Concept]
   737   C0947322:Manufacturer [Intellectual Product]
   737 E C1521902:Specify [Qualitative Concept]
   737   C1705426:Manufacturer [Population Group]

Phrase: "(Boehringer Mannheim"

Phrase: ")."
Processing 00000000.tx.67: Western blot Confluent cells were incubated for 24 h either with a cytokine cocktail [interleukin-1 (IL-1) 10 ng/ml, interferon (INF-) 10 ng/ml, tumor necrosis factor (TNF)- 25 ng/ml and lipopolysaccharides (LPS) 10 g/ml] as positive control and/or with steroid and nonsteroid ligands (17-estradiol, progesterone, 17-estradiol, tamoxifen, and ICI 182,780) as described in the figure legends. 

Phrase: "Western blot Confluent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h either"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with a cytokine cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678420:Cocktail [Food]

Phrase: "[interleukin-1 (IL-1) 10 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439275:ng/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "interferon (INF-) 10 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "tumor necrosis factor (TNF)- 25 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "lipopolysaccharides (LPS) 10 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml] as positive control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and/or with steroid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1706528:And/Or [Conceptual Entity]
   770   C0038317:Steroid [Steroid]
   770   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "nonsteroid ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "(17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "progesterone,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "tamoxifen,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ICI 182,780"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "as"

Phrase: "described in the figure legends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552738:described [Idea or Concept]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.68: The incubation was ended by addition of sample buffer (0.125 M Tris-HCl pH 6.8, 40 mM EDTA, 4.6% SDS, 20% glycerol). 

Phrase: "The incubation"

Phrase: "was"

Phrase: "ended by addition of sample buffer"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0370003:Sample [Substance]
   753   C1272693:Ended [Qualitative Concept]
   753   C1883712:Addition [Functional Concept]
   753   C2347026:Sample [Conceptual Entity]
   753   C2746065:Ended [Temporal Concept]
   719 E C0444930:End [Spatial Concept]

Phrase: "(0.125 M Tris-HCl pH 6.8,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   864   C0126577:M-8 [Organic Chemical,Pharmacologic Substance]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0441923:M+ [Intellectual Product]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: "40 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "4.6% SDS,"

Phrase: "20% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.69: Protein concentration was measured according to Lowrys method with BSA as a standard (29) and twenty-eight-microgram proteins were separated on SDS-denaturating PAGE using discontinuous gradient gels (105%) (30). 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured according to Lowrys method"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   797   C0449768:Measured to [Quantitative Concept]
   760   C0025663:Method [Intellectual Product]
   760   C0444706:Measured [Qualitative Concept]
   760   C0449851:Method [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0871511:METHOD [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "with BSA"

Phrase: "as a standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "twenty-eight-microgram proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated on SDS-denaturating PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "discontinuous gradient gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "(105%"

Phrase: ")"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.70: Proteins were electrophoretically transferred to nitrocellulose membranes. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "electrophoretically"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.71: Immunoblotting was performed with the polyclonal antirabbit NOS II antibody (1:1000 dilution in BSA 5%, Transduction Laboratories, Inc.) 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "was"

Phrase: "performed with the polyclonal antirabbit NOS II antibody"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   757   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0030015:oxide [Inorganic Chemical]
   739   C0884358:Performed [Functional Concept]
   739   C2986642:oxide [Chemical Viewed Functionally]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 dilution in BSA 5%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]

Phrase: "Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."

Phrase: ")"
Processing 00000000.tx.72: and with the secondary peroxidase conjugated goat antirabbit antibody (1:2000 dilution in BSA 5%, Bio-Rad Laboratories, Inc.), which was then revealed by enhanced chemiluminescence (ECL, Amersham). 

Phrase: "and with the secondary peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0027627:secondary [Neoplastic Process]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   760   C1515981:And [Idea or Concept]

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "goat antirabbit antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 dilution in BSA 5%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]

Phrase: "Bio-Rad Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "revealed by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0443289:Revealed [Qualitative Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "Amersham"

Phrase: ")."
Processing 00000000.tx.73: Antibody specificity was assayed by testing extracts from cytokine-stimulated rat peritoneal macrophages. 

Phrase: "Antibody specificity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0003264:Antibody Specificity [Molecular Function]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "assayed by testing extracts"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0022885:Test [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737   C2828366:Extract [Substance]

Phrase: "from cytokine-stimulated rat peritoneal macrophages."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0206190:Macrophages, Peritoneal [Cell]
   804   C0024432:Macrophages [Cell]
   804   C0031153:Peritoneal [Body Part, Organ, or Organ Component]
   804   C0442034:peritoneal [Body Location or Region]
   804   C1546706:Macrophages [Intellectual Product]
   804   C1550652:Macrophages [Body Substance]
   804   C1882823:Rat Peritoneum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.74: To compare the NOS II content in the experimental samples, scanning densitometry was performed; 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the NOS II content in the experimental samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]

Phrase: "scanning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034606:Scanning [Diagnostic Procedure]
  1000   C0441633:Scanning [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.75: care was taken to ensure that the OD of all the bands considered were in the range of linearity previously assessed. 

Phrase: "care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the OD of all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0029421:OD [Disease or Syndrome]
   770   C0439164:OD [Quantitative Concept]
   770   C1512019:OD [Intellectual Product]

Phrase: "the bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "were in the range of linearity previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.76: Nitrite assay Confluent cells were stimulated for 24 h with the cytokines cocktail in the presence or absence of either 17-estradiol or progesterone at different concentrations. 

Phrase: "Nitrite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028137:Nitrite [Chemical Viewed Structurally]
  1000   C1384115:Nitrite [Inorganic Chemical]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "Confluent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "with the cytokines cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678420:Cocktail [Food]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of either 17-estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "progesterone at different concentrations."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   770   C2757070:Progesterone [Pharmacologic Substance]
   715 E C0010094:Corpus luteum hormone [Hormone]
   715 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   715 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   715 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.77: Nitrite production was determined in the cell culture supernatants by the Griess reaction (31). 

Phrase: "Nitrite production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "determined in the cell culture supernatants"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007585:Cell Culture [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719   C1550101:Supernatant [Body Substance]

Phrase: "by the Griess reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.78: Briefly, 200 l of the supernatant were placed in each well of a 96-well plate. 

Phrase: "Briefly,"

Phrase: "200 l of the supernatant"

Phrase: "were"

Phrase: "placed in each well of a 96-well plate."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0005971:Plate [Medical Device]
   742   C0205170:Well [Qualitative Concept]
   742   C1139930:plate [Medical Device]
   742   C3146287:Well [Manufactured Object]
   742   C3537155:Plate [Manufactured Object]
   708   C0442504:Place [Spatial Concept]
   708   C1704765:Place [Functional Concept]
   708   C1882509:Place [Activity]
   708   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.79: Subsequently, 20 l of 6.5 M hydrochloric acid and 20 l of 37.5 mM sulfanilic acid were added. 

Phrase: "Subsequently,"

Phrase: "20 l of 6.5 M hydrochloric acid"

Phrase: "and"

Phrase: "20 l of 37.5 mM sulfanilic acid"

Phrase: "were"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.80: After incubation for 10 min at room temperature, 20 l of 12.5 mM N(1-napthyl)ethylendiamine was added. 

Phrase: "After incubation"

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature, 20 l"

Phrase: "of 12.5 mM N(1-napthyl"

Phrase: ")"

Phrase: "ethylendiamine"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.81: Thirty minutes later, the OD was read at 550 nm and compared with a standard curve which showed a linearity range between 0.045 and 2.0 mol/mg protein. 

Phrase: "Thirty minutes later,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439232:minute [Temporal Concept]
   827   C0700321:minute [Quantitative Concept]
   827   C0702093:/minute [Temporal Concept]
   827   C1282918:Minute [Quantitative Concept]
   827   C2347166:Minute [Quantitative Concept]

Phrase: "the OD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029421:OD [Disease or Syndrome]
  1000   C0439164:OD [Quantitative Concept]
  1000   C1512019:OD [Intellectual Product]

Phrase: "was"

Phrase: "read at 550 nm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034754:Read [Daily or Recreational Activity]
   770   C0312860:NM [Cell Function]
   770   C1705179:read [Finding]

Phrase: "and"

Phrase: "compared with a standard curve"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205134:Curve [Spatial Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C1707455:Compared [Activity]
   760   C2828392:Standard [Intellectual Product]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a linearity range between 0.045"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "2.0 mol/mg protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.82: Protein content was determined on cell extracts by the Bradfords method (32) and used to normalize the nitrite values. 

Phrase: "Protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined on cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007634:Cell [Cell]
   790   C1269647:Cell [Cell]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]

Phrase: "extracts by the Bradfords method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C2828366:Extract [Substance]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the nitrite values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.83: Statistical analysis For NOS II protein accumulation, values are expressed as densitometric units. 

Phrase: "Statistical analysis For NOS II protein accumulation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0871424:statistical analysis [Research Activity]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as densitometric units."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439148:Units [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.84: Data are obtained from three different experiments, and each value represents the mean  SD. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "obtained from three different experiments,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1301820:Obtained [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "each value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  SD."
Processing 00000000.tx.85: In experiments in which NOS II activity was measured, statistical analysis was performed with one-way ANOVA, followed by Fishers test. 

Phrase: "In experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "in which NOS II activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   933   C1151383:nitric-oxide synthase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed with one-way ANOVA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   862   C1709320:One-way ANOVA [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "followed by Fishers test."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   816   C1708064:Fisher's Test [Intellectual Product]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   737   C0325045:Fisher [Mammal]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.86: Each value represents the mean  SEM of three different experiments (run in triplicate).  

Phrase: "Each value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  SEM of three different experiments"

Phrase: "(run in triplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205174:Triplicate [Quantitative Concept]
   734   C3274438:RUN-IN [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.87: Results Top Abstract Introduction Materials and Methods Results Discussion References  17-estradiol removal causes an increase in the NOS II content in SMC As reported by several authors, the NOS II protein content is barely detectable by Western blot analysis in SMC grown in medium containing phenol red (M199 + FCS; see Fig. 1A, lane 1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "17-estradiol removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015252:Removal [Therapeutic or Preventive Procedure]
   827   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in the NOS II content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "in SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "As"

Phrase: "reported by several authors,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1709908:Reported By [Group]
   770   C0221193:Authors [Professional or Occupational Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "the NOS II protein content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0423896:Content [Mental Process]
   799   C0456205:Content [Conceptual Entity]
   734   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "barely detectable by Western blot analysis"

Phrase: "in SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "grown"

Phrase: "in medium containing phenol red"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   804   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   804   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   804   C0332575:Red [Finding]
   804   C1260956:Red [Qualitative Concept]
   733 E C0359916:phenolic [Organic Chemical,Pharmacologic Substance]

Phrase: "(M199 + FCS"

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.88: However, these cells express a high concentration of NOS II protein in response to inflammatory stimuli, such as 24 h treatment with the cytokine cocktail (10 ng/ml interleukin-1, 10 ng/ml interferon , 25 ng/ml tumor necrosis factor , and 10 g/ml lipopolysaccharides), which leads to an increase in NOS immunoreactivity of about 2570 fold with respect to controls. 

Phrase: "However,"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "a high concentration of NOS II protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0427716:Protein concentration [Laboratory Procedure]
   762   C1304757:Protein concentration [Laboratory or Test Result]
   742   C0086045:Concentration [Mental Process]
   742   C1446561:Concentration [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to inflammatory stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "such as 24 h treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "with the cytokine cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678420:Cocktail [Food]

Phrase: "(10 ng/ml interleukin-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1334110:NG.1 [Gene or Genome]
   840   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "10 ng/ml interferon ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "25 ng/ml tumor necrosis factor ,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   861   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1323304:tumor necrosis factor [Molecular Function]
   861   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0333516:Tumor necrosis [Neoplastic Process]
   799   C0027540:Necrosis [Organ or Tissue Function]
   799   C0027651:Tumor [Neoplastic Process]
   799   C1334928:Necrosis [Finding]
   799   C1521761:Factor [Functional Concept]
   799   C1578706:Tumor [Intellectual Product]
   799   C2827422:Factor [Conceptual Entity]
   799   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "10 g/ml lipopolysaccharides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023810:Lipopolysaccharides [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "leads to an increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0442805:Increase [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in NOS immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597879:immunoreactivity [Molecular Function]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of about 2570 fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "with respect to controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.89: Interestingly, when SMC were grown in the absence of phenol red and serum (wM199), NOS II content was significantly increased (of about 50%) with respect to cytokine-stimulated cells (Fig. 1B, compare lanes 2 and 3). 

Phrase: "Interestingly,"

Phrase: "when"

Phrase: "SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "grown in the absence of phenol red"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   748   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C0332575:Red [Finding]
   748   C1260956:Red [Qualitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "(wM199"

Phrase: ")"

Phrase: ","

Phrase: "NOS II content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "("

Phrase: "of about 50%"

Phrase: ")"

Phrase: "with respect to cytokine-stimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.90: To verify whether this increase was due to the well described estrogen-like activity of phenol red, we tested the effect of estrogen addition. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "whether"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was due to the well described estrogen-like activity of phenol red,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   753   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0678226:Due to [Functional Concept]
           due
   736   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   736   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   736   C0043194:WAS [Disease or Syndrome]
   736   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   736   C0205170:Well [Qualitative Concept]
   736   C0205177:Activity [Functional Concept]
   736   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0332575:Red [Finding]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1260956:Red [Qualitative Concept]
   736   C1421478:WAS [Gene or Genome]
   736   C1552738:described [Idea or Concept]
   736   C1561536:*Activity [Idea or Concept]
   736   C2936882:Estrogen [Pharmacologic Substance]
   736   C3146286:Due [Idea or Concept]
   736   C3146287:Well [Manufactured Object]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effect of estrogen addition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0877035:Estrogen Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.91: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 1B shows that the presence of 17-estradiol at concentration as low as 0.01 nM is sufficient to reduce the NOS II protein content to the levels measured in complete medium (M199 + FCS). 

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the presence of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 0.01 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "reduce"

Phrase: "the NOS II protein content to the levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]

Phrase: "measured in complete medium"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0009458:Medium [Intellectual Product]
   770   C0205197:Complete [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0725685:COMPLEAT [Food]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(M199 + FCS"

Phrase: ")."
Processing 00000000.tx.93: The effect is maintained at 1 nM 17-estradiol. 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "at 1 nM 17-estradiol."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]
   708   C0104487:AT 17 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.94: View larger version (7K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(7K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.95: Estrogen decreases NOS II protein content in SMC. 

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "NOS II protein content in SMC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.96: A, Vascular SMC were grown for 6 days in complete medium (M199 + FCS, lane 1) or in phenol red-free medium for 5 days and then deprived of FCS for 24 h (wM199, lanes 2 and 3). 

Phrase: "A,"

Phrase: "Vascular SMC"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "grown for 6 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "in complete medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(M199 + FCS,"

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or in phenol red-free medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C1541709:Red free [Qualitative Concept]
   753   C0009458:Medium [Intellectual Product]
   753   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0332296:free [Functional Concept]
   753   C0332575:Red [Finding]
   753   C0439536:Medium [Quantitative Concept]
   753   C1260956:Red [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "for 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "deprived of FCS"

Phrase: "for 24 h (wM199,"

Phrase: "lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.97: Cells were stimulated for 24 h with cytokine-cocktail (+ cytok., lane 2). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "with cytokine-cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678420:Cocktail [Food]

Phrase: "(+ cytok.,"

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.98: B, SMC were grown as in A (lanes 13) or in the presence of increasing concentrations of 17-estradiol (10-1310-9 M) (lanes 46). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "as in A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1706746:Agarose Gel [Research Device]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0036681:Agarose [Carbohydrate]
   770   C1382104:Gel [Substance]

Phrase: "(lanes 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or in the presence of increasing concentrations of 17-estradiol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   739   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   739   C0086045:Concentrations [Mental Process]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0442808:Increasing [Functional Concept]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "(10-1310-9"

Phrase: "M) ("

Phrase: "lanes 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.99: Equal amounts of proteins were loaded in each lane (28 g). 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "loaded in each lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "(28 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.100: Quantitation of NOS II content was performed by scanning densitometry of the 130-kDa band following staining with specific polyclonal anti-NOS II antibody using a peroxidase linked secondary antibody. 

Phrase: "Quantitation of NOS II content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "performed by scanning densitometry of the 130-kDa band"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C1550369:Performed By [Qualitative Concept]
   742   C0011321:Densitometry [Laboratory Procedure]
           densitometric scanning
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C0441633:Scanning [Diagnostic Procedure]
   742   C0884358:Performed [Functional Concept]
   742   C1521913:band [Cell Component]
   742   C1532717:kDa [Quantitative Concept]
   708 E C2826292:SCAN [Finding]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "staining with specific polyclonal anti-NOS II antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0487602:Staining [Laboratory Procedure]
   739   C1704680:Staining [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "secondary antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.101: A Western analysis representative of a single experiment and the graph corresponding to means  SD of three independent experiments are shown.  

Phrase: "A Western analysis representative of a single experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1882932:Representative [Activity]

Phrase: "and"

Phrase: "the graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "corresponding to means  SD of three independent experiments"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0332291:Independent of [Functional Concept]
   744   C0085862:Independent [Idea or Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0681814:Experiments [Research Activity]
   744   C1299583:Independent [Finding]
   744   C1704970:Means [Conceptual Entity]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C1706386:Experiment [Conceptual Entity]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.102: This observation suggests that estradiol may control NOS II synthesis in SMC at concentrations compatible with ER activation. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "may"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "NOS II synthesis in SMC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C1157570:nitric oxide synthesis [Molecular Function]
   742   C0220781:synthesis [Biologic Function]
   742   C1883254:Synthesis [Activity]
   726   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "compatible with ER activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]
Processing 00000000.tx.103: Analysis of estrogen receptor mRNA content in SMC To prove that the SMC grown in vitro were expressing the estrogen receptor isoforms and , total RNA from cells at the 4th and 9th passage of growth was retrotranscribed and amplified by PCR with specific primer sets. 

Phrase: "Analysis of estrogen receptor mRNA content"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0681915:content analysis [Research Activity]
   774   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in SMC To"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "prove"

Phrase: "that"

Phrase: "the SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "grown"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "were"

Phrase: "expressing"

Phrase: "the estrogen receptor isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: ","

Phrase: "total RNA from cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at the 4th"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205438:4th [Quantitative Concept]

Phrase: "and"

Phrase: "9th passage of growth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439799:Passage [Spatial Concept]

Phrase: "was"

Phrase: "retrotranscribed"

Phrase: "and"

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "with specific primer sets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.104: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.105: 2A shows that cells at the 4th passage express ER mRNA (lane 2), while, at the conditions used in this assay, no amplification product was observed from cells grown at the 9th passage (lane 3). 

Phrase: "2A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that cells at the 4th passage"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "ER mRNA (lane 2"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   904   C1121713:Estrogen Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   904   C1414462:ESTROGEN RECEPTOR 2 [Gene or Genome]
   904   C1523984:Estrogen Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   827   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   827   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   799   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0335218:Messenger [Professional or Occupational Group]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1708639:Lane [Spatial Concept]
   799   C2936882:Estrogen [Pharmacologic Substance]
   727 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: ","

Phrase: "at the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used in this assay,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "no amplification product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "observed from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "grown at the 9th passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439799:Passage [Spatial Concept]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.106: In another series of experiments, we could demonstrate that in SMC grown in vitro the expression of ER decreases progressively with time in culture and, by the 8th passage, it falls below the detection limits of our assay. 

Phrase: "In another series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "could"

Phrase: "demonstrate"

Phrase: "that in SMC"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1135918:Smooth Muscle Cells [Cell]
   806   C0596981:Muscle Cells [Cell]
   806   C1267092:Muscle, Smooth [Tissue]
   760   C0007634:Cells [Cell]
   760   C0026845:Muscle [Tissue]
   760   C0205357:Smooth [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "grown"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "the expression of ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "progressively with time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: ","

Phrase: "by the 8th passage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "it"

Phrase: "falls below the detection"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0085639:Fall [Finding]
   770   C0238715:Fall [Temporal Concept]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "limits of our assay."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0439801:limit [Functional Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C1549649:Limit [Idea or Concept]
   770   C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.107: As a consequence, in our experiments we used only cells between the 2nd and 6th passage in culture (data not shown). 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "in our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "only cells between the 2nd"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "6th passage in culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439799:Passage [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: View larger version (6K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(6K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.109: Expression of ER isoforms mRNA in rat SMC. 

Phrase: "Expression of ER isoforms mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0040649:RNA Expression [Genetic Function]
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat SMC."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.110: Total RNA extracted from rat uterus (lane 1) and from SMC at 4th (lane 2, 4 and 5) or 9th passage (lane 3) was assayed for RT-PCR in the presence (lanes 14) or absence (lanes 5) of reverse transcriptase. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from rat uterus"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1882904:Rat Uterus [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0042149:Uterus [Body Part, Organ, or Organ Component]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1269032:Uterus [Body Part, Organ, or Organ Component]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and from SMC"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1135918:Smooth Muscle Cells [Cell]
   806   C0596981:Muscle Cells [Cell]
   806   C1267092:Muscle, Smooth [Tissue]
   760   C0007634:Cells [Cell]
   760   C0026845:Muscle [Tissue]
   760   C0205357:Smooth [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at 4th"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205438:4th [Quantitative Concept]

Phrase: "(lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "4"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "9th passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "assayed for RT-PCR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(lanes 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(lanes 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "of reverse transcriptase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.111: Bands of the expected molecular weight (A, 254 bp for ER-; B, 262 bp for ER-) were observed after separation of the amplified product on agarose gel (A) and subsequent Southern blot analysis (B).  

Phrase: "Bands of the expected molecular weight"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0175723:Bands [Medical Device]
   719 E C0439645:Band [Spatial Concept]
   719 E C1521913:band [Cell Component]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "254 bp for ER"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "-"

Phrase: "; B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "262 bp for ER"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "-"

Phrase: ")"

Phrase: "were"

Phrase: "observed after separation of the amplified product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0036679:Separation [Pathologic Function]
   748   C0237868:Separation [Social Behavior]
   748   C1441672:Observed [Functional Concept]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
   748   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "on agarose gel (A)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "subsequent Southern blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   923   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   812   C1710133:Southern [Spatial Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.112: In the case of ER-, to ensure that the amplification product corresponded to the ER- sequence, a Southern blot analysis of the specific PCR amplification product was performed. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of ER-"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0332285:Of [Spatial Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the amplification product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "corresponded to the ER-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   806   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "a Southern blot analysis of the specific PCR amplification product"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   785   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   770   C0005862:Southern blot analysis [Molecular Biology Research Technique]
           Southern Blot
   770   C1148472:southern blot analysis [Laboratory or Test Result]
           Blot, Southern
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]
   736   C1710133:Southern [Spatial Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.113: Figure 2B shows the autoradiography of RT-PCR and Southern blot for ER-; 

Phrase: "Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the autoradiography of RT-PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004400:Autoradiography [Laboratory Procedure]

Phrase: "and"

Phrase: "Southern blot for ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0005862:Southern Blot [Molecular Biology Research Technique]
   806   C1148472:Blot, Southern [Laboratory or Test Result]
   760   C1710133:Southern [Spatial Concept]

Phrase: "-"

Phrase: ";"
Processing 00000000.tx.114: a specific amplification signal of the expected size of 262 bp is detected in SMC cDNA (lane 4), whereas a control sample, in which the reverse transcriptase was omitted from the cDNA reaction, did not show any amplification product, suggesting that no DNA contamination was present in any step of the experimental procedure (lane 5). 

Phrase: "a specific amplification signal of the expected size of 262 bp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "detected in SMC cDNA (lane 4"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C1135918:Smooth Muscle Cells [Cell]
   764   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0596981:Muscle Cells [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   742   C0007634:Cells [Cell]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026845:Muscle [Tissue]
   742   C0205357:Smooth [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1708639:Lane [Spatial Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "a control sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "in which"

Phrase: "the reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]

Phrase: "was"

Phrase: "omitted from the cDNA reaction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0443286:Reaction [Functional Concept]
   753   C0750563:omitted [Idea or Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any amplification product,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "no DNA contamination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   861   C0259846:contamination [Human-caused Phenomenon or Process]
   861   C1881659:CONTAMINATION [Event]
   861   C2349974:Contamination [Idea or Concept]

Phrase: "was"

Phrase: "present in any step of the experimental procedure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0450011:Present procedure [Therapeutic or Preventive Procedure]
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "(lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.115: NOS II content in SMC is controlled by the state of activation of ER To verify whether activation of the ER was mediating the hormone-dependent decrease in NOS II content previously described, we investigated the effect of two antagonists of ER, ICI 182,780 and tamoxifen, which block the estrogen-induced transcriptional activity of the receptor. 

Phrase: "NOS II content in SMC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0423896:Content [Mental Process]
   742   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "controlled by the state of activation of ER To"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   760   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0332298:Controlled by [Functional Concept]
   760   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   760   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C1514758:Receptor Activation [Cell Function]
   739   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1301808:State [Geographic Area]
   739   C1442792:State [Functional Concept]
   739   C1879547:Activation [Activity]
   739   C2587213:Controlled [Functional Concept]
   739   C2936882:Estrogen [Pharmacologic Substance]
   739   C3148680:State [Geographic Area]
   706 E C0243148:control [Qualitative Concept]
   706 E C1550141:Control [Substance]
   706 E C1882979:Control [Conceptual Entity]
   706 E C3274648:Control [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "whether"

Phrase: "activation of the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514758:Receptor Activation [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the hormone-dependent decrease in NOS II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0520971:Hormone decrease [Laboratory or Test Result]
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of two antagonists of ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0877035:Estrogen Effect [Finding]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "ICI 182,780"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "tamoxifen,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the estrogen-induced transcriptional activity of the receptor."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   789   C1148776:estrogen receptor activity [Molecular Function]
   767   C1152633:receptor activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.116: Figure 3 shows that in cells grown in medium without estrogen (phenol red-free medium, wM199) NOS II protein immunoreactivity is relatively high, and treatment with 0.01 nM 17-estradiol reduces its levels of about 90%. 

Phrase: "Figure 3"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "grown"

Phrase: "in medium without estrogen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "(phenol red-free medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "wM199"

Phrase: ")"

Phrase: "NOS II protein immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0597879:immunoreactivity [Molecular Function]
   734   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "relatively high,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "treatment with 0.01 nM 17-estradiol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "reduces"

Phrase: "its levels of about 90%."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.117: A dose of 10 nM tamoxifen was able to block 17-estradiol effect, leading NOS II protein content to a level very close to that of cells grown in wM199 alone. 

Phrase: "A dose of 10 nM tamoxifen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "17-estradiol effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "NOS II protein content to a level very"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C0428479:Protein level [Laboratory or Test Result]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]

Phrase: "close to that of cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0587267:Close [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "grown in wM199"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.118: Interestingly, in the presence of ICI 182,780 the levels of NOS II protein were even higher than in wM199 alone. 

Phrase: "Interestingly,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ICI 182,780"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]

Phrase: "the levels of NOS II protein"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0428479:Protein level [Laboratory or Test Result]
   750   C0441926:Level II [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "even higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in wM199"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.119: This observation is not reconcilable with a blockade of the effect of estrogen-like compounds, which might still be present in wM199, because in all of our experiments we failed to see any effect of ICI 182,780 or tamoxifen alone (data not shown). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "not reconcilable with a blockade of the effect of estrogen-like compounds,"

Phrase: "which"

Phrase: "might"

Phrase: "still"

Phrase: "be"

Phrase: "present in wM199,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "because in all of our experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "we"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "any effect of ICI 182,780"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "tamoxifen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: The double band recognized by NOS II antibody, in samples where NOS is present at high concentrations, could result from the recognition of heterogeneous NOS subunits, as reported by other authors (33). 

Phrase: "The double band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "recognized by NOS II antibody,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in samples where NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "present at high concentrations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "could"

Phrase: "result from the recognition of heterogeneous NOS subunits,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0019409:Heterogeneous [Qualitative Concept]
   739   C0030015:oxide [Inorganic Chemical]
   739   C0524637:Recognition [Mental Process]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]
   739   C2986642:oxide [Chemical Viewed Functionally]
   706   C1711351:Subunit [Quantitative Concept]

Phrase: "as"

Phrase: "reported by other authors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1709908:Reported By [Group]
   770   C0221193:Authors [Professional or Occupational Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.121: View larger version (10K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.122: Tamoxifen and ICI 182,780 blockade of estrogen-induced decrease of NOS II protein content. 

Phrase: "Tamoxifen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   944 E C0919390:Nolvadex [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ICI 182,780 blockade of estrogen-induced decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332206:Blockade [Functional Concept]
   744   C3540676:Blockade [Pharmacologic Substance]

Phrase: "of NOS II protein content."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0423896:Content [Mental Process]
   799   C0456205:Content [Conceptual Entity]
   734   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.123: Cells were treated with 10-11 M 17-estradiol alone or in the presence of 10-8 M tamoxifen (TAM, lane 5) or 10-8 M ICI 182,780 (ICI, lane 6) for 24 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 10-11 M 17-estradiol"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in the presence of 10-8 M tamoxifen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0126577:M-8 [Organic Chemical,Pharmacologic Substance]
   742   C0039286:Tamoxifen [Organic Chemical,Pharmacologic Substance]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0441923:M+ [Intellectual Product]

Phrase: "(TAM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039286:TAM [Organic Chemical,Pharmacologic Substance]
  1000   C0410207:TAM [Disease or Syndrome]
  1000   C1834582:TAM [Neoplastic Process]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "10-8 M ICI 182,780"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]
   799   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441923:M+ [Intellectual Product]

Phrase: "(ICI,"

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.124: Lanes 1 and 2 represent unstimulated and cytokine-stimulated cells, respectively. 

Phrase: "Lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "unstimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439819:Unstimulated [Qualitative Concept]

Phrase: "and"

Phrase: "cytokine-stimulated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.125: The Western analysis is representative of a single experiment while the graph reports the means  SD of three independent experiments are shown.  

Phrase: "The Western analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "representative of a single experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "while"

Phrase: "the graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the means  SD of three independent experiments"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.126: To evaluate the specificity of estrogen action, we also studied the effects on NOS II protein of another sex steroid, progesterone. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the specificity of estrogen action,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "we also"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effects on NOS II protein of another sex steroid,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C1280500:effects [Qualitative Concept]
   703 E C2348382:Effect [Qualitative Concept]

Phrase: "progesterone."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.127: Unlike 17-estradiol, progesterone did not affect NOS II levels assessed by immunoreactivity when used at concentrations sufficient to fully activate its cognate receptor (10-9 M). 

Phrase: "Unlike 17-estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "NOS II levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   823   C0441926:ii level [Intellectual Product]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "assessed by immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597879:immunoreactivity [Molecular Function]
   790   C1516048:Assessed [Activity]

Phrase: "when"

Phrase: "used at concentrations sufficient to fully"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0086045:Concentrations [Mental Process]
   753   C0205410:Sufficient [Qualitative Concept]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1446561:Concentration [Quantitative Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "its cognate receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(10-9"

Phrase: "M)."
Processing 00000000.tx.128: A decrease in NOS II accumulation, however, was observed at supraphysiological progesterone concentrations (10-7 M) (Fig. 4). 

Phrase: "A decrease in NOS II accumulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "however,"

Phrase: "was"

Phrase: "observed at supraphysiological progesterone concentrations"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   760   C0086045:Concentrations [Mental Process]
   760   C1441672:Observed [Functional Concept]
   760   C2757070:Progesterone [Pharmacologic Substance]
   726 E C1446561:Concentration [Quantitative Concept]
   704 E C0010094:Corpus luteum hormone [Hormone]
   704 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   704 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   704 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(10-7"

Phrase: "M) ("

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.129: View larger version (12K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.130: Progesterone does not affect NOS II protein content in SMC. 

Phrase: "Progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "NOS II protein content in SMC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0423896:Content [Mental Process]
   739   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.131: Control (lane 1), cytokine-stimulated (lane 2) and unstimulated cells (lane 3) grown in wM199 were treated as in Fig. 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "cytokine-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "unstimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "grown in wM199"

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.132: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.133: Treatment with 17-estradiol 10-11 M (lane 4) or with increasing concentrations of progesterone (from 10-1110-9 M, lanes 57) was carried out for 24 h. 

Phrase: "Treatment with 17-estradiol 10-11"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "M ("

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or with increasing concentrations of progesterone"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   753   C0086045:Concentrations [Mental Process]
   753   C0442808:Increasing [Functional Concept]
   753   C2757070:Progesterone [Pharmacologic Substance]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "("

Phrase: "from 10-1110-9 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "lanes 57"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for 24 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0439787:Out [Spatial Concept]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.134: A representative Western analysis and graph corresponding to means  SD of three independent experiments are shown.  

Phrase: "A representative Western analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "corresponding to means  SD of three independent experiments"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0332291:Independent of [Functional Concept]
   744   C0085862:Independent [Idea or Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0681814:Experiments [Research Activity]
   744   C1299583:Independent [Finding]
   744   C1704970:Means [Conceptual Entity]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C1706386:Experiment [Conceptual Entity]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.135: Effects of 17-estradiol and progesterone on nitrite production and NOS II synthesis The supernatants of SMC were then assayed to investigate whether the estrogen-induced changes in NOS II protein reflected also changes in nitrite accumulation. 

Phrase: "Effects of 17-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "progesterone on nitrite production"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   770   C2757070:Progesterone [Pharmacologic Substance]
   715 E C0010094:Corpus luteum hormone [Hormone]
   715 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   715 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   715 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "NOS II synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C1157570:nitric oxide synthesis [Molecular Function]
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "The supernatants of SMC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the estrogen-induced changes in NOS II protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   741   C0025320:The change [Physiologic Function]
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "also"

Phrase: "changes in nitrite accumulation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0028137:Nitrite [Chemical Viewed Structurally]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1384115:Nitrite [Inorganic Chemical]
   770   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.136: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.137: 5, when nitrites were measured in unstimulated cells, the treatment with estradiol did not have any significant consequence; 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "when"

Phrase: "nitrites"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028137:Nitrites [Chemical Viewed Structurally]
   966 E C1384115:Nitrite [Inorganic Chemical]

Phrase: "were"

Phrase: "measured in unstimulated cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0439819:Unstimulated [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3282337:Cells [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the treatment with estradiol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any significant consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:Consequence [Functional Concept]

Phrase: ";"
Processing 00000000.tx.138: we believe that this is principally due to the lack of sensitivity of the methodology used. 

Phrase: "we"

Phrase: "believe"

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "principally due to the lack of sensitivity of the methodology"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0036667:Sensitivity [Quantitative Concept]
   739   C0312418:Sensitivity [Mental Process]
   739   C0332268:lack [Qualitative Concept]
   739   C0427965:Sensitivity [Finding]
   739   C0969625:methodology [Intellectual Product]
   739   C1511883:Sensitivity [Quantitative Concept]
   739   C1522640:Sensitivity [Qualitative Concept]
   739   C2346484:SENSITIVITY [Phenomenon or Process]
   739   C2349185:Sensitivity [Qualitative Concept]
   739   C3146286:Due [Idea or Concept]
   739   C3266812:Methodology [Idea or Concept]
   722   C0332324:Sensitive to [Functional Concept]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.139: In fact, we did not detect any difference in NO production even in cells grown in M199 + FCS or in wM199, whereas the NOS enzyme levels were significantly different (see results shown in Fig. 1, lanes 1 and 3). 

Phrase: "In fact,"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any difference in NO production even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown"

Phrase: "in M199 + FCS"

Phrase: "or in wM199,"

Phrase: "whereas"

Phrase: "the NOS enzyme levels"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   840   C0014440:enzyme levels [Laboratory Procedure]
   840   C1287349:enzyme levels [Laboratory or Test Result]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "shown in Fig. 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.140: Estradiol, however, at concentrations as low as 0.01 nM, significantly diminished the nitrites in the medium of cytokine-stimulated cells. 

Phrase: "Estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "however,"

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 0.01 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "significantly"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "the nitrites in the medium of cytokine-stimulated cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0028137:Nitrites [Chemical Viewed Structurally]
   708 E C1384115:Nitrite [Inorganic Chemical]
Processing 00000000.tx.141: This observation clearly suggests that estradiol significantly reduces the extent of cytokine-induced production of NO. 

Phrase: "This observation clearly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that estradiol significantly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "reduces"

Phrase: "the extent of cytokine-induced production of NO."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.142: Consistent with our previously data, progesterone was capable of decreasing the nitrite content in the medium only at pharmacological concentrations. 

Phrase: "Consistent with our previously data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "was"

Phrase: "capable of decreasing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the nitrite content in the medium only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "at pharmacological concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.143: View larger version (9K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.144: Dose-response effect of 17-estradiol and progesterone on cytokine-induced nitrite production. 

Phrase: "Dose-response effect of 17-estradiol"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1280500:Effect [Qualitative Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2348382:Effect [Qualitative Concept]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "progesterone on cytokine-induced nitrite production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   753   C2757070:Progesterone [Pharmacologic Substance]
Processing 00000000.tx.145: Vascular SMC were assayed in the presence of vehicle (-) or the cytokines cocktail (+) for 24 h and the hormonal effects were assessed by adding increasing concentrations of 17-estradiol (10-1110-8 M) and progesterone (10-910-6 M) at the same time as cytokines. 

Phrase: "Vascular SMC"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "assayed in the presence of vehicle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0042444:Vehicle [Biomedical or Dental Material]
   753   C0348005:Vehicle [Manufactured Object]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "(-"

Phrase: ")"

Phrase: "or"

Phrase: "the cytokines cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678420:Cocktail [Food]

Phrase: "(+"

Phrase: ")"

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the hormonal effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "assessed by adding increasing concentrations of 17-estradiol"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   744   C0086045:Concentrations [Mental Process]
   744   C0442808:Increasing [Functional Concept]
   744   C1516048:Assessed [Activity]
   711 E C1446561:Concentration [Quantitative Concept]
   711   C1883712:Add [Functional Concept]

Phrase: "(10-1110-8"

Phrase: "M)"

Phrase: "and"

Phrase: "progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(10-910-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0439187:/10^6 [Quantitative Concept]
   913   C1881839:10^6 [Quantitative Concept]

Phrase: "M) at the same time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0445247:Same [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "as cytokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.146: Nitrite production was measured in the cell culture supernatants by the Griess reaction. 

Phrase: "Nitrite production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "measured in the cell culture supernatants"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0007585:Cell Culture [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0444706:Measured [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1550101:Supernatant [Body Substance]

Phrase: "by the Griess reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.147: Data represent the mean  SEM of three experiments, each run in triplicate. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  SEM of three experiments,"

Phrase: "each run in triplicate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205174:Triplicate [Quantitative Concept]
   734   C3274438:RUN-IN [Temporal Concept]
Processing 00000000.tx.148: All comparison were made against cytokine-stimulated cells (*, P < 0.05: ANOVA followed by Fishers test for multiple comparison).  

Phrase: "All comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "made against cytokine-stimulated cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726   C1881534:Make [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ":"

Phrase: "ANOVA"

Phrase: "followed by Fishers"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756   C0325045:Fisher [Mammal]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "test for multiple comparison"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1707455:Comparison [Activity]

Phrase: ")."
Processing 00000000.tx.149: We further investigated whether 17-estradiol had any effect on NOS II level in cytokine-stimulated cells. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "had"

Phrase: "any effect on NOS II level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in cytokine-stimulated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.150: Figure 6 shows that estradiol at nanomolar concentrations significantly reduced the cytokine-induction of NOS II protein, thus confirming the results obtained with the nitrite assay. 

Phrase: "Figure 6"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that estradiol at nanomolar concentrations significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the cytokine-induction of NOS II protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "thus"

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with the nitrite assay."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0028137:Nitrite [Chemical Viewed Structurally]
   760   C0243073:assay [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1384115:Nitrite [Inorganic Chemical]
   760   C1510438:Assay [Laboratory Procedure]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.151: View larger version (10K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.152: 17-estradiol decreases NOS II content in cytokine-stimulated SMC. 

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "NOS II content in cytokine-stimulated SMC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0423896:Content [Mental Process]
   738   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.153: Vascular SMC were grown in M199 + FCS (lane 1) or in wM199 + cytokine cocktail in the absence (lane 2) or presence of 10-11 M 17-estradiol (lane 3) for 24 h. 

Phrase: "Vascular SMC"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "grown"

Phrase: "in M199 + FCS"

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or in wM199 + cytokine cocktail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0678420:Cocktail [Food]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 10-11 M 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.154: Data in the graph correspond to means  SD of three independent experiments.   

Phrase: "Data in the graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "correspond to means  SD of three independent experiments."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0332291:Independent of [Functional Concept]
   744   C0085862:Independent [Idea or Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0681814:Experiments [Research Activity]
   744   C1299583:Independent [Finding]
   744   C1704970:Means [Conceptual Entity]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C1706386:Experiment [Conceptual Entity]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.155: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  The results reported in this paper prove that estradiol, by interacting with its cognate receptor, reduces the accumulation and activity of NOS II in rat SMC. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reported in this paper"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0030351:Paper [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1547566:Paper [Idea or Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "prove"

Phrase: "that estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "by interacting"

Phrase: "with its cognate receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "reduces"

Phrase: "the accumulation"

Phrase: "and"

Phrase: "activity of NOS II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1151383:nitric-oxide synthase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   716   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in rat SMC."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.156: The finding that ER- and ER- are both expressed in these cells indicate that the effect here reported might be due to the activation of either receptors. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "-"

Phrase: "and"

Phrase: "ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "-"

Phrase: "are"

Phrase: "both"

Phrase: "expressed in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the effect here"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "might"

Phrase: "be due to the activation of either receptors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   750   C1514758:Receptor Activation [Cell Function]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C1879547:Activation [Activity]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
Processing 00000000.tx.157: Previous studies proved that estradiol increases NOS III mRNA and activity in vascular endothelial cells (19, 20) and in a variety of other tissues (34). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "proved"

Phrase: "that estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "NOS III mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0335218:Messenger [Professional or Occupational Group]

Phrase: "and"

Phrase: "activity in vascular endothelial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: "and in a variety of other tissues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0040300:Tissues [Tissue]
   748   C1515981:And [Idea or Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   714 E C1547928:Tissue [Intellectual Product]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.158: In the present study, for the first time in a well defined cell system, we provide evidence of an effect of estradiol on NOS II. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "for the first time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "in a well defined cell system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence of an effect of estradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "on NOS II."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.159: These results are in agreement with in vivo studies by Kauser et al. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with in vivo studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0681829:in vivo study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "by Kauser et al."
Processing 00000000.tx.160: (35). 

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.161: On the other hand, ex vivo studies by Binko (36) and Kauser (37), have shown contrasting results in NOS II protein following estradiol treatment of endothelium-denuded aortic rings. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "ex vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348480:ex vivo [Functional Concept]
   861   C1515655:vivo [Spatial Concept]

Phrase: "studies by Binko"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "(36"

Phrase: ")"

Phrase: "and"

Phrase: "Kauser"

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "contrasting results in NOS II protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "estradiol treatment of endothelium-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "denuded"

Phrase: "aortic rings."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0225957:Aortic ring [Body Part, Organ, or Organ Component]
   861   C1260969:Rings [Medical Device]
   827 E C0521164:Ring [Spatial Concept]
   827 E C1705184:Ring [Medical Device]
Processing 00000000.tx.162: The apparent discrepancies might be related to the different protocols of NOS II stimulation and hormone concentration used. 

Phrase: "The apparent discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1290905:discrepancies [Finding]

Phrase: "might"

Phrase: "be"

Phrase: "related to the different protocols of NOS II stimulation"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   797   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   756   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   738   C0030015:oxide [Inorganic Chemical]
   738   C0439849:Related [Qualitative Concept]
   738   C0442711:Protocols [Intellectual Product]
   738   C0445223:Related [Finding]
   738   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   738   C1705242:Different [Qualitative Concept]
   738   C1948023:Stimulation [Natural Phenomenon or Process]
   738   C2986642:oxide [Chemical Viewed Functionally]
   704 E C0163712:Relate [Organic Chemical]
   704 E C1507394:Protocol [Intellectual Product]
   704 E C1522729:Protocol [Intellectual Product]
   704 E C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "hormone concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.163: However, it is worth to underline that in the above studies the hormonal effect on NOS II protein levels were evaluated in the presence of endothelial cells. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "worth to"

Phrase: "underline"

Phrase: "that in the above"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "the hormonal effect on NOS II protein levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "evaluated in the presence of endothelial cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   804   C0427850:Presence of cells [Laboratory or Test Result]
   778   C0225336:Endothelial Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0220825:Evaluated [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: Because it is well known that these latter cells are sensitive to estrogen action, their initial presence in the preparation could influence the SMC response. 

Phrase: "Because"

Phrase: "it"

Phrase: "is"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that"

Phrase: "these latter cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "sensitive to estrogen action,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "their initial presence in the preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "influence"

Phrase: "the SMC response."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C1135918:Smooth Muscle Cells [Cell]
Processing 00000000.tx.165: Unlike the other forms of NOS so far described (NOS I and NOS III) (23), NOS II is considered as the high throughput path for NO production, which is reserved for mechanisms involving host defense, like infection and inflammation. 

Phrase: "Unlike the"

Phrase: "other forms of NOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(NOS I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039112:Synthase I [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NOS III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "NOS II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "considered as the high throughput path"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205250:High [Qualitative Concept]
   753   C0750591:considered [Idea or Concept]
   753   C0919386:PATH [Laboratory Procedure]
   753   C1299351:High [Qualitative Concept]
   753   C1705483:Path [Intellectual Product]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "for NO production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "which"

Phrase: "is"

Phrase: "reserved for mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0441712:Mechanisms [Functional Concept]
   756 E C1706376:Mechanism [Manufactured Object]
   756   C2347957:Reserve [Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "host defense,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520990:Host defence [Organ or Tissue Function]
   861   C1880266:Defense [Conceptual Entity]

Phrase: "like infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "and"

Phrase: "inflammation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]
Processing 00000000.tx.166: The production of NOS II by SMC may play a role in the formation of the atherosclerotic plaque dependent on sustained inflammatory reactions occurring within the vessel wall. 

Phrase: "The production of NOS II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "by SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the formation of the atherosclerotic plaque"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "dependent on sustained inflammatory reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "occurring within the vessel wall."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0005847:Vessel [Body Part, Organ, or Organ Component]
   760   C0677535:Wall [Manufactured Object]
   760   C1511228:Vessel [Tissue]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.167: The estrogen-mediated prevention of cytokine-induced production of NO and NOS II by SMC shown in Figs. 

Phrase: "The estrogen-mediated prevention of cytokine-induced production of NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0199176:Prevention [Therapeutic or Preventive Procedure]
   739   C1706420:PREVENTION [Research Activity]
   739   C2700409:prevention [Qualitative Concept]

Phrase: "and"

Phrase: "NOS II by SMC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "shown in Figs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   756 E C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.168: 5 and 6 suggests the potential for an antiinflammatory role played by this hormone, which might be of great interest also with regard to a possible protective role exerted by estrogen in other pathologies, such as multiple sclerosis (38) and Alzheimers disease (39, 40, 41), in which immune responses play a relevant role. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the potential for an antiinflammatory role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "played by this hormone,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0019932:Hormone [Hormone]
   770   C0600138:played [Finding]
   737 E C0032214:Play [Daily or Recreational Activity]

Phrase: "which"

Phrase: "might"

Phrase: "be of great interest also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0543488:Interest [Mental Process]
   760   C0549177:Great [Quantitative Concept]
   760   C1704243:Great [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "with regard to a possible protective role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "exerted by estrogen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   790   C0015264:Exerted [Organism Function]
   790   C2936882:Estrogen [Pharmacologic Substance]
   718 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "in other pathologies,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0030664:Pathologies [Biomedical Occupation or Discipline]
   966 E C0205469:pathology [Functional Concept]
   966 E C0677042:pathology [Pathologic Function]
   916 E C1521733:Pathologic [Functional Concept]

Phrase: "such as multiple sclerosis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0026769:Multiple Sclerosis [Disease or Syndrome]
  1000   C1417325:multiple sclerosis [Gene or Genome]
   861   C0036429:Sclerosis [Pathologic Function]
   861   C0439064:Multiple [Quantitative Concept]
   789 E C0334135:Sclerotic [Functional Concept]

Phrase: "(38"

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "in which immune responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0301872:immune responses [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a relevant role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.169: Interestingly, recent studies carried out in macrophages, and our unpublished observations in microglial cells, demonstrated that progesterone (42) and estradiol (43) decrease NO production following cytokine stimulation. 

Phrase: "Interestingly,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in macrophages,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0024432:Macrophages [Cell]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   790   C1546706:Macrophages [Intellectual Product]
   790   C1550652:Macrophages [Body Substance]

Phrase: "and"

Phrase: "our unpublished observations in microglial cells,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0302523:observations [Research Activity]
   753   C0700325:observations [Health Care Activity]
   753   C3244290:observations [Functional Concept]
   719 E C1964257:Observation [Diagnostic Procedure]

Phrase: "demonstrated"

Phrase: "that progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
  1000   C2757070:Progesterone [Pharmacologic Substance]
   944 E C0010094:Corpus luteum hormone [Hormone]
   944 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(42"

Phrase: ")"

Phrase: "and"

Phrase: "estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(43"

Phrase: ")"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "NO production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cytokine stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.170: The question as to how estrogen negatively regulates NOS II is still open. 

Phrase: "The question as to how estrogen negatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522634:Question [Intellectual Product]

Phrase: "regulates"

Phrase: "NOS II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "still"

Phrase: "open."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]
Processing 00000000.tx.171: It is known that NOS II can be transcriptionally regulated, at least in rodent cells (23). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that NOS II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "transcriptionally"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in rodent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: Studies with IL-1 in rat vascular smooth muscle cells (44) and with IL-1 or cAMP-elevating agents (45) in rat glomerular cells prove that NOS II transcriptional control is not restricted to a single cell type or regulator. 

Phrase: "Studies with IL-1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "in rat vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "(44"

Phrase: ")"

Phrase: "and with IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1515981:And [Idea or Concept]
   770   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "cAMP-elevating agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "(45"

Phrase: ")"

Phrase: "in rat glomerular cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007634:Cells [Cell]
   827   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   827   C0268731:GLOMERULAR [Disease or Syndrome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "prove"

Phrase: "that NOS II transcriptional control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1158770:Transcriptional Control [Genetic Function]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   734   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restricted to a single cell type"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0007634:Cell Type [Cell]
           Cell
   790   C0449475:cell type [Intellectual Product]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0443288:Restricted [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "regulator."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0182953:REGULATOR [Medical Device]
  1000   C1704734:Regulator [Medical Device]
  1000   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.173: The complexity of NOS II promoter suggests that a substantial number of factors may participate in its regulation. 

Phrase: "The complexity of NOS II promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   731   C2263441:complex II [Molecular Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a substantial number of factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "may"

Phrase: "participate in its regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.174: The fact that we did not identify any consensus binding site for the ER does not eliminate the possibility of a direct interaction between ER and NOS II promoter. 

Phrase: "The fact"

Phrase: "that"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "identify"

Phrase: "any consensus binding site for the ER"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C0034804:Estrogen receptor site [Amino Acid, Peptide, or Protein,Receptor]
   793   C1149369:estrogen receptor binding [Molecular Function]
   770   C0005456:Binding Site [Receptor]
           Receptor site, NOS
   770   C0682969:Binding Site [Amino Acid Sequence]
   767   C0597358:Receptor Binding [Molecular Function]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "eliminate"

Phrase: "the possibility of a direct interaction"

Phrase: "between ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "NOS II promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.175: By interacting with other factors, such as AP-1 or NF-kB components, estrogen could directly influence NOS II mRNA synthesis (46). 

Phrase: "By interacting"

Phrase: "with other factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "such as AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "NF-kB components,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]
   734   C0079904:NF-kB [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "influence"

Phrase: "NOS II mRNA synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   900   C1157570:nitric oxide synthesis [Molecular Function]
   818   C1328948:RNA Synthesis [Molecular Function]
   818   C1623415:RNA synthesis [Genetic Function]
   795   C0220781:synthesis [Biologic Function]
   795   C1883254:Synthesis [Activity]
   710   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.176: It has been shown that NF-B-mediated induction of the IL-6 promoter, which does not contain any ERE consensus sequence, can be blocked by estrogen through the interaction of the ER with members of the NF-B family of transcription factors (47, 48, 49). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that NF-B-mediated induction of the IL-6 promoter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "any ERE consensus sequence,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0079160:Consensus Sequence [Nucleotide Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0376298:Consensus [Social Behavior]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by estrogen"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2936882:Estrogen [Pharmacologic Substance]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
   718 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "through the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "of the ER"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "with members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the NF-B family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "of transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(47,"

Phrase: "48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.177: On the other hand, our study does not exclude the possibility of a posttranscriptional control of NOS II mRNA or protein; 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of a posttranscriptional control of NOS II mRNA"

Phrase: "or"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.178: several reports proved that NOS II can be regulated by mRNA destabilization or by posttranslational mechanisms also in rat SMC (50). 

Phrase: "several reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "proved"

Phrase: "that NOS II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1533698:Nitric Oxide Synthase II [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "regulated by mRNA destabilization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C1327288:RNA destabilization [Genetic Function]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0335218:Messenger [Professional or Occupational Group]
   760   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "or by posttranslational mechanisms also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "in rat SMC"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.179: In conclusion, our study might suggest that estradiol exerts an antiinflammatory activity in rat SMC through a decreased NO production. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   944 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "an antiinflammatory activity in rat SMC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   731   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "through a decreased NO production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]
Processing 00000000.tx.180: This effect is not observed with progesterone. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed with progesterone."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   790   C1441672:Observed [Functional Concept]
   790   C2757070:Progesterone [Pharmacologic Substance]
   734 E C0010094:Corpus luteum hormone [Hormone]
   734 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   734 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   734 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.181: Thus, the negative regulation of NOS II enzyme may represent another mechanism associated with the beneficial effects of estrogen in cardiovascular disorders.  

Phrase: "Thus,"

Phrase: "the negative regulation of NOS II enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205160:Negative [Qualitative Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]
   742   C1513916:Negative [Finding]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "another mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "associated with the beneficial effects of estrogen"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0877035:Estrogen Effects [Finding]
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C1280500:effects [Qualitative Concept]
   748   C2936882:Estrogen [Pharmacologic Substance]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in cardiovascular disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007222:Cardiovascular Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.182: Acknowledgments  We are grateful to Dr. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.183: Alan Wakeling for providing us with the estrogen receptor antagonist ICI 182,780.  

Phrase: "Alan Wakeling for providing"

Phrase: "us with the estrogen receptor antagonist ICI 182,780."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1123005:ICI 182,780 [Pharmacologic Substance,Steroid]
   790   C2267020:Estrogen Receptor Antagonist [Pharmacologic Substance]
   764   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   764   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0014930:Estrogen antagonist [Pharmacologic Substance]
   742   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   742   C0231491:Antagonist [Organ or Tissue Function]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.184: Footnotes  1 This work was partly supported by European Economic Community (CEE) BIOMED (BMH497-2286), Telethon (Grant C600), National Research Center (CNR) Targeted Project Biotechnology, Istituto Superiore della Sanita Progetto Sclerosi Multipla and Italian Association for Cancer Research (AIRC). 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "partly"

Phrase: "supported by European Economic Community"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0600216:European Economic Community [Organization]
   797   C0015179:European Community [Organization]
   760   C0009462:Community [Geographic Area]
   760   C0013556:Economic [Occupation or Discipline]
   760   C0013557:Economic [Functional Concept]
   760   C0239307:European [Population Group]
   760   C1521721:Supported [Conceptual Entity]
   760   C1535514:European [Population Group]
   726 E C0183683:Support [Medical Device]

Phrase: "(CEE) BIOMED"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332030:Biomed [Health Care Related Organization]

Phrase: "(BMH497-2286"

Phrase: ")"

Phrase: ","

Phrase: "Telethon"

Phrase: "(Grant C600"

Phrase: ")"

Phrase: ","

Phrase: "National Research Center (CNR) Targeted Project Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Istituto Superiore della Sanita Progetto Sclerosi Multipla"

Phrase: "and"

Phrase: "Italian Association for Cancer Research (AIRC)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
Processing 00000000.tx.185: Received August 17, 1998.  

Phrase: "Received August 17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1998."
Processing 00000000.tx.186: References Top Abstract Introduction Materials and Methods Results Discussion References  Barret-Connor E, Bush TL 1991 Estrogen and coronary heart disease in women. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Barret-Connor E,"

Phrase: "Bush TL 1991 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "coronary heart disease in women."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   926   C2362528:Heart Disease in Women [Disease or Syndrome]
   862   C0010054:coronary heart disease [Disease or Syndrome]
   862   C0010068:Coronary heart disease [Disease or Syndrome]
           Coronary Disease
   806   C0018799:Heart disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0018787:Heart [Body Part, Organ, or Organ Component]
           coronary
   760   C1281570:Heart [Body Part, Organ, or Organ Component]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.187: J Am Med Assoc 265:18611867[Abstract] Wenger NK, Speroff L, Packard B 1993 Cardiovascular health and disease in women. 

Phrase: "J"

Phrase: "Am"

Phrase: "Med Assoc 265"

Phrase: ":"

Phrase: "18611867"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wenger NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Speroff L,"

Phrase: "Packard B 1993 Cardiovascular health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0018684:Health [Idea or Concept]
   704 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "disease in women."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.188: N Engl J Med 329:247256[Free FullText] Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the nurses health study. 

Phrase: "N Engl J Med 329"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "247256"

Phrase: "[Free FullText"

Phrase: "] Stampfer MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Colditz GA,"

Phrase: "Willett WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Manson JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Rosner B,"

Phrase: "Speizer FE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "Hennekens CH 1991 Postmenopausal estrogen therapy"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   799   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   799   C0039798:therapy [Functional Concept]
   799   C0087111:Therapy [Therapeutic or Preventive Procedure]
   799   C1363945:Therapy [Finding]
   799   C2936882:Estrogen [Pharmacologic Substance]
   727 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "ten year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439234:year [Temporal Concept]
   861   C0439508:/year [Temporal Concept]

Phrase: "follow-up from the nurses health study."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0016441:Follow-up Study [Research Activity]
   778   C0589120:Follow-up [Finding]
   778   C1522577:follow-up [Health Care Activity]
   778   C1704685:FOLLOW-UP [Intellectual Product]
   778   C3274571:FOLLOW-UP [Health Care Activity]
   748   C0332283:follow [Temporal Concept]
   748   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.189: N Engl J Med 325:756762[Abstract] Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR 1992 Hormone therapy to prevent disease and prolong life in postmenopausal women. 

Phrase: "N Engl J Med 325"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "756762"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Grady D,"

Phrase: "Rubin SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Petitti DB,"

Phrase: "Fox CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Black D,"

Phrase: "Ettinger B,"

Phrase: "Ernster VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: "Cummings SR 1992 Hormone therapy to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0279025:Hormone Therapy [Therapeutic or Preventive Procedure]
   799   C0019932:Hormone [Hormone]
   799   C0039798:therapy [Functional Concept]
   799   C0087111:Therapy [Therapeutic or Preventive Procedure]
   799   C1363945:Therapy [Finding]
   727 E C0458083:Hormonal [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "prolong"

Phrase: "life in postmenopausal women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0376558:Life [Idea or Concept]
Processing 00000000.tx.190: Ann Intern Med 117:10161037[Medline] Bush TL 1990 The epidemiology of cardiovascular disease in postmenopausal women. 

Phrase: "Ann Intern Med 117"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1144859:INTERN [Professional or Occupational Group]

Phrase: ":"

Phrase: "10161037"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bush TL 1990"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0330099:Bush [Plant]

Phrase: "The epidemiology of cardiovascular disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   760   C0014508:epidemiology [Functional Concept]
   760   C0699910:epidemiology [Health Care Activity]

Phrase: "in postmenopausal women."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043210:Women [Population Group]
   861   C0232970:postmenopausal [Temporal Concept]
Processing 00000000.tx.191: Ann NY Acad Sci 592:263271[Abstract] Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA 1988 Postmenopausal use of estrogen and occlusion of coronary arteries. 

Phrase: "Ann NY Acad Sci 592"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "263271"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gruchow HW,"

Phrase: "Anderson AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Barboriak JJ,"

Phrase: "Sobocinski KA 1988 Postmenopausal use of estrogen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1524063:Use of [Functional Concept]
   774   C0239301:ESTROGEN USE [Finding]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "occlusion of coronary arteries."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   870   C0264995:Occlusion of artery [Pathologic Function]
           artery occlusion
   865   C0151814:Coronary artery occlusion [Disease or Syndrome]
           Coronary Occlusion
   770   C0011382:Occlusion [Organ or Tissue Function]
   770   C0028778:Occlusion [Pathologic Function]
   770   C0441597:Occlusion [Functional Concept]
   770   C1110554:OCCLUSION [Pathologic Function]
   770   C1882137:OCCLUSION [Phenomenon or Process]
   770   C1947917:Occlusion, NOS [Functional Concept]
Processing 00000000.tx.192: Am Heart J 115:954963[Medline] Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. 

Phrase: "Am"

Phrase: "Heart J 115"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "954963"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Walsh BW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005910:BW [Organism Attribute]
   861   C0006041:BW [Geographic Area]
   861   C2986891:BW [Idea or Concept]

Phrase: "Schiff I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rosner B,"

Phrase: "Greenberg L,"

Phrase: "Ravnikar V,"

Phrase: "Sacks FM 1991 Effects of postmenopausal estrogen replacement"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0877035:Estrogen Effects [Finding]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on the concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "metabolism of plasma lipoproteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1158917:lipoproteins metabolism [Molecular Function]
   819   C1373181:Plasma Metabolism [Organism Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.193: N Engl J Med 325:11961204[Abstract] Bush TL, Barret-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM 1987 Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. 

Phrase: "N Engl J Med 325"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "11961204"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bush TL,"

Phrase: "Barret-Connor E,"

Phrase: "Cowan LD,"

Phrase: "Criqui MH,"

Phrase: "Wallace RB,"

Phrase: "Suchindran CM,"

Phrase: "Tyroler HA,"

Phrase: "Rifkind BM 1987 Cardiovascular mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026565:Mortality [Quantitative Concept]
   804   C0026566:mortality [Quantitative Concept]

Phrase: "and"

Phrase: "noncontraceptive use of estrogen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1524063:Use of [Functional Concept]
   819   C0239301:ESTROGEN USE [Finding]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: ":"

Phrase: "results from the Lipid Research Clinics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:research results [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "Program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "Follow-up Study."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0016441:Follow-up Study [Research Activity]
   901   C0589120:Follow-up [Finding]
   901   C1522577:follow-up [Health Care Activity]
   901   C1704685:FOLLOW-UP [Intellectual Product]
   901   C3274571:FOLLOW-UP [Health Care Activity]
   827   C0332283:follow [Temporal Concept]
   827   C0557651:Study [Manufactured Object]
   827   C1719822:Follow [Intellectual Product]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.194: Circulation 75:11021109[Abstract] Farhat MY, Lavigne MC, Ramwell PW 1996 The vascular protective effects of estrogen. 

Phrase: "Circulation 75"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "11021109"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Farhat"

Phrase: "MY,"

Phrase: "Lavigne MC,"

Phrase: "Ramwell PW 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242397:PW [Geographic Area]

Phrase: "The vascular protective effects of estrogen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0877035:Estrogen Effects [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.195: FASEB J 10:615624[Abstract/Free FullText] Mendelsohn ME, Karas RH 1994 Estrogen and the blood vessel wall. 

Phrase: "FASEB J 10"

Phrase: ":"

Phrase: "615624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mendelsohn"

Phrase: "ME,"

Phrase: "Karas RH 1994 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the blood vessel wall."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1180033:Blood vessel wall [Body Part, Organ, or Organ Component]
   827   C0677535:Wall [Manufactured Object]
   734   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   734   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   734   C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.196: Curr Opin Cardiol 9:619626[Medline] Colbburn P, Buonassisi V 1978 Estrogen-binding sites in endothelial cell cultures. 

Phrase: "Curr Opin Cardiol 9"

Phrase: ":"

Phrase: "619626"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Colbburn P,"

Phrase: "Buonassisi V 1978 Estrogen-binding sites in endothelial cell cultures."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0005456:Binding Sites [Receptor]
   739   C0205145:Sites [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   726 E C0682969:Binding Site [Amino Acid Sequence]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.197: Science 201:817819[Medline] Nakao J, Chang WC, Murota SI, Orimo H 1981 Estradiol-binding sites in rat aortic smooth muscle cells in culture. 

Phrase: "Science 201"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "817819"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakao J,"

Phrase: "Chang WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Murota SI,"

Phrase: "Orimo H 1981 Estradiol-binding sites in rat aortic smooth muscle cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0005456:Binding Sites [Receptor]
   736   C0205145:Sites [Spatial Concept]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   719 E C0682969:Binding Site [Amino Acid Sequence]
   703 E C1515974:Site [Body Location or Region]
   703 E C2825164:Site [Spatial Concept]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.198: Atherosclerosis 38:7580[Medline] Karas RH, Patterson BL, Mendelsohn ME 1994 Human vascular smooth muscle cells contain functional estrogen receptor. 

Phrase: "Atherosclerosis 38"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0004153:Atherosclerosis [Disease or Syndrome]
   789 E C0333482:Atherosclerotic [Functional Concept]

Phrase: ":"

Phrase: "7580"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Karas RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Patterson BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Mendelsohn"

Phrase: "ME 1994 Human vascular smooth muscle cells"
Meta Candidates (Total=20; Excluded=7; Pruned=0; Remaining=13)
   876   C0427861:Human cells [Laboratory or Test Result]
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   808   C0005773:Blood Cells [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1801960:Vascular [Qualitative Concept]
   799 E C2328697:Hemal cell [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "functional estrogen receptor."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   901   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.199: Circulation 89:19431950[Abstract] Orimo A, Inoue S, Ouchi Y, Orimo H 1995 Vascular smooth muscle cells possess estrogen receptor and respond to estrogen. 

Phrase: "Circulation 89"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "19431950"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Orimo A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "Inoue S,"

Phrase: "Ouchi Y,"

Phrase: "Orimo H 1995 Vascular smooth muscle cells"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   845   C0026844:Muscle, Smooth, Vascular [Tissue]
   845   C1135918:Smooth Muscle Cells [Cell]
   818   C0596981:Muscle Cells [Cell]
   818   C1267092:Muscle, Smooth [Tissue]
   795   C0005773:Blood Cells [Cell]
   795   C0005847:vascular [Body Part, Organ, or Organ Component]
   795   C0007634:Cells [Cell]
   795   C0026845:Muscle [Tissue]
   795   C0205357:Smooth [Qualitative Concept]
   795   C1558950:VASCULAR [Finding]
   795   C1801960:Vascular [Qualitative Concept]
   795   C3282337:Cells [Cell]
   787 E C2328697:Hemal cell [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   740 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   740 E C1511228:VESSEL, BLOOD [Tissue]
   724 E C0442025:Muscular [Spatial Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "estrogen receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "respond to estrogen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   790   C2936882:Estrogen [Pharmacologic Substance]
   718 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.200: Ann NY Acad Sci 758:592594 Venkov CD, Rankin AB, Vaughan DE 1996 Identification of authentic estrogen receptor in cultured endothelial cells. 

Phrase: "Ann NY Acad Sci 758"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "592594 Venkov CD,"

Phrase: "Rankin AB,"

Phrase: "Vaughan DE 1996 Identification of authentic estrogen receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "in cultured endothelial cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.201: A potential mechanism for steroid hormone regulation of endothelial function. 

Phrase: "A potential mechanism for steroid hormone regulation of endothelial function."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.202: Circulation 94:727733[Abstract/Free FullText] Kuiper GGJM, Gustafsson J- 1997 The novel estrogen receptor- subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. 

Phrase: "Circulation 94"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "727733"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuiper GGJM,"

Phrase: "Gustafsson J- 1997"

Phrase: "The novel estrogen receptor- subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449560:Subtype [Classification]

Phrase: ":"

Phrase: "potential role in the cell-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "promoter-specific actions of estrogens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205369:Specific [Qualitative Concept]
   760   C0441472:actions [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "anti-estrogens."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0014930:Anti-Estrogens [Pharmacologic Substance]
   861   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   827 E C2936882:Estrogen [Pharmacologic Substance]
   777 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.203: FEBS Lett 410:8790[CrossRef][Medline] Beato M 1989 Gene regulation by steroid hormones. 

Phrase: "FEBS Lett 410"

Phrase: ":"

Phrase: "8790"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beato M 1989 Gene regulation by steroid hormones."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017263:Gene Regulation [Genetic Function]
   767   C0920552:hormones regulation [Organism Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.204: Cell 56:335344[Medline] Kauser K, Rubanyi GM 1994 Gender differences in bioassayable endothelium-derived nitric oxide release from isolated rat aortae. 

Phrase: "Cell 56"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "335344"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kauser K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rubanyi GM 1994 Gender differences in bioassayable endothelium-derived nitric oxide release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036866:gender differences [Organism Attribute]
   703   C1705241:*Difference [Quantitative Concept]
   703   C1705242:Difference [Qualitative Concept]

Phrase: "from isolated rat aortae."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   793   C0003483:Aorta [Body Part, Organ, or Organ Component]
   793   C1278934:Aorta [Body Part, Organ, or Organ Component]
Processing 00000000.tx.205: Am J Physiol 267:H2311H2317 Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G 1995 Gender differences in atherosclerosis: possible role of nitric oxide. 

Phrase: "Am"

Phrase: "J Physiol 267"

Phrase: ":"

Phrase: "H2311H2317 Hayashi T,"

Phrase: "Fukuto JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Ignarro LJ,"

Phrase: "Chaudhuri G 1995 Gender differences in atherosclerosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0036866:gender differences [Organism Attribute]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: ":"

Phrase: "possible role of nitric oxide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.206: J Cardiovasc Pharmacol 22:6568 Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A 1995 Estrogen increases endothelial nitric oxide by a receptor-mediated system. 

Phrase: "J Cardiovasc Pharmacol 22"

Phrase: ":"

Phrase: "6568 Hayashi T,"

Phrase: "Yamada K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Esaki T,"

Phrase: "Kuzuya M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Satake S,"

Phrase: "Ishikawa T,"

Phrase: "Hidaka H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Iguchi A 1995 Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   804   C2936882:Estrogen [Pharmacologic Substance]
   733 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "endothelial nitric oxide by a receptor-mediated system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1097411:receptor, nitric oxide [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0030015:oxide [Inorganic Chemical]
   744   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.207: Biochem Biophys Res Commun 195:435441[CrossRef] Cooke JP, Dzau VJ 1997 Nitric oxide synthase: role in the genesis of cardiovascular disease. 

Phrase: "Biochem Biophys Res Commun 195"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "435441"

Phrase: "[CrossRef"

Phrase: "] Cooke JP,"

Phrase: "Dzau VJ 1997 Nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   827   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   799   C0030015:oxide [Inorganic Chemical]
   799   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ":"

Phrase: "role in the genesis of cardiovascular disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.208: Annu Rev Med 48:489509[CrossRef][Medline] Frstermann U, Nakane M, Tracey WR, Pollock JS 1993 Isoforms of nitric oxide synthase: functions in the cardiovascular system. 

Phrase: "Annu Rev Med 48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "489509"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Frstermann U,"

Phrase: "Nakane M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tracey WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "Pollock JS 1993 Isoforms of nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "functions in the cardiovascular system."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   835   C0678859:cardiovascular functions system [Organ or Tissue Function]
   781   C0007227:Cardiovascular function [Organ or Tissue Function]
   760   C0542341:Functions [Functional Concept]
   756   C1180473:Functional system [Body System]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.209: Eur Heart J [Suppl I] 14:1015 Frstermann U, Kleinert H 1995 Nitric oxide synthase: expression and expressional control of the three isoforms. 

Phrase: "Eur Heart J [Suppl I] 14"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1015 Frstermann U,"

Phrase: "Kleinert H 1995 Nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   827   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   799   C0030015:oxide [Inorganic Chemical]
   799   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ":"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "expressional control of the three isoforms."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.210: Naunyn-Schmiedebergs Arch Pharmacol 352:351364[Medline] Buttery LDK, Springall DR, Chester AH, Evans TJ, Standfield N, Parums DV, Yacoub MH, Polak JM 1996 Inducible nitric oxide synthase is present within human atherosclerotic lesion and promotes the formation and activity of peroxinitrite. 

Phrase: "Naunyn-Schmiedebergs Arch Pharmacol 352"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0230467:arch [Body Location or Region]
   804   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "351364"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Buttery LDK,"

Phrase: "Springall DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Chester AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Evans TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Standfield N,"

Phrase: "Parums DV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0279354:DV [Therapeutic or Preventive Procedure]
   861   C1704645:DV [Conceptual Entity]

Phrase: "Yacoub MH,"

Phrase: "Polak JM 1996 Inducible nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   877   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   818   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   795   C0030015:oxide [Inorganic Chemical]
   795   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "present within human atherosclerotic lesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "activity of peroxinitrite."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.211: Lab Invest 75:77185[Medline] Ross R 1971 The smooth muscle cell. 

Phrase: "Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]

Phrase: "Invest"

Phrase: "75"

Phrase: ":"

Phrase: "77185"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ross R 1971"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205090:R- [Spatial Concept]
   827   C0331968:Ross [Health Care Related Organization]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   827   C2699100:Ross [Bird]

Phrase: "The smooth muscle cell."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1135918:Smooth muscle cell [Cell]
   901   C0596981:Muscle cell [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cell [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.212: II. 

Phrase: "II."
Processing 00000000.tx.213: Growth of smooth muscle in culture and formation of elastic fibres. 

Phrase: "Growth of smooth muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "formation of elastic fibres."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.214: J Cell Biol 50:172186[Abstract/Free FullText] Skalli O, Ropraz P, Trezclak A, Benzonana G, Gillessen D, Gabbiani G 1986 A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. 

Phrase: "J Cell Biol 50"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "172186"

Phrase: "[Abstract/Free FullText"

Phrase: "] Skalli O,"

Phrase: "Ropraz P,"

Phrase: "Trezclak A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "Benzonana G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Gillessen D,"

Phrase: "Gabbiani G 1986 A monoclonal antibody against alpha-smooth muscle actin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   782   C1718642:Actin.smooth muscle Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0201511:Antibody Smooth Muscle [Laboratory Procedure]
   767   C0369998:Smooth muscle antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0443887:Muscle antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   736   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   736   C0746619:monoclonal [Finding]

Phrase: ":"

Phrase: "a new probe for smooth muscle differentiation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0182400:Probe [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.215: J Cell Biol 103:27872796[Abstract] Santagati S, Garnier M, Carlo P, Violani E, Picotti GB, Maggi A 1997 Quantitation of low abundance mRNAs in glial cells using different polymerase chain reaction (PCR)-based methods. 

Phrase: "J Cell Biol 103"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "27872796"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Santagati S,"

Phrase: "Garnier M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Carlo P,"

Phrase: "Violani E,"

Phrase: "Picotti GB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]

Phrase: "Maggi A 1997 Quantitation of low abundance mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709793:Quantitation [Quantitative Concept]

Phrase: "in glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different polymerase chain reaction (PCR)-based methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0025663:Methods [Intellectual Product]
   799   C0025664:methods [Intellectual Product]
   799   C0449851:Methods [Functional Concept]
   766 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.216: Brain Research Protocols 1:217223[CrossRef][Medline] Santagati S, Bettini E, Asdente M, Muramatsu M, Maggi A 1993 Theoretical considerations for the application of competitive polymerase chain reaction to the quantitation of a low abundance mRNA: estrogen receptor. 

Phrase: "Brain Research Protocols 1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C0442711:Protocols [Intellectual Product]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   779 E C1507394:Protocol [Intellectual Product]
   779 E C1522729:Protocol [Intellectual Product]
   779 E C2348563:Protocol [Intellectual Product]

Phrase: ":"

Phrase: "217223"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Santagati S,"

Phrase: "Bettini E,"

Phrase: "Asdente M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Muramatsu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maggi A 1993 Theoretical considerations for the application of competitive polymerase chain reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0518609:considerations [Finding]

Phrase: "to the quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "of a low abundance mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0335218:Messenger [Professional or Occupational Group]

Phrase: ":"

Phrase: "estrogen receptor."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.217: Biochem Pharmacol 46:17971803[CrossRef][Medline] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. 

Phrase: "Biochem Pharmacol 46"

Phrase: ":"

Phrase: "17971803"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lowry OH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "Rosebrough NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Farr AL,"

Phrase: "Randall RJ 1951 Protein measurement with the Folin phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0202202:Protein measurement [Laboratory Procedure]
   757   C0202446:Phenol measurement [Laboratory Procedure]
   739   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.218: J Biol Chem 193:265275[Free FullText] Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. 

Phrase: "J Biol Chem 193"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "265275"

Phrase: "[Free FullText"

Phrase: "] Laemmli UK 1970 Cleavage of structural proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "during the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "of the bacteriophage T4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162570:Bacteriophage T4 [Virus]
Processing 00000000.tx.219: Nature 227:680685[Medline] Robbins RA, Springall BR, Worren JB, Kwon OJ, Buttery LDK, Wilson AJ, Adcock IM, Riveros-Moreno B, Moncada S, Polack J, Barnes PJ 1994 Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. 

Phrase: "Nature 227"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "680685"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Robbins RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Springall BR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704648:Br. [Conceptual Entity]

Phrase: "Worren JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Kwon OJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718895:OJ [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Buttery LDK,"

Phrase: "Wilson AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Adcock IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "Riveros-Moreno B,"

Phrase: "Moncada S,"

Phrase: "Polack J,"

Phrase: "Barnes PJ 1994 Inducible nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   877   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   877   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   818   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   795   C0030015:oxide [Inorganic Chemical]
   795   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "increased in murine lung epithelial cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0014597:Epithelial Cells [Cell]
   790   C1273342:Epithelial Cells [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0024109:Lung [Body Part, Organ, or Organ Component]
   753   C0026809:Murine [Mammal]
   753   C0205217:Increased [Quantitative Concept]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C0819757:LUNG [Tissue]
   753   C1278908:Lung [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "by cytokine stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.220: Biochem Biophys Res Commun 198:835843[CrossRef][Medline] Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. 

Phrase: "Biochem Biophys Res Commun 198"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "835843"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bradford MM 1976 A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1706746:Agarose Gel [Research Device]
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method for the quantitation of microgram quantities of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1547724:Quantity method [Idea or Concept]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "utilising"

Phrase: "the principle of protein-dye binding."
Processing 00000000.tx.221: Anal Biochem 72:248254[CrossRef][Medline] Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF 1991 Purification and characterisation of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. 

Phrase: "Anal Biochem 72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "248254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stuehr DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Cho HJ,"

Phrase: "Kwon NS,"

Phrase: "Weise MF,"

Phrase: "Nathan CF 1991 Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243114:purification [Functional Concept]
   812   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterisation of the cytokine-induced macrophage nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: ":"

Phrase: "an FAD-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3247466:FAD [Pharmacologic Substance]

Phrase: "and"

Phrase: "FMN-containing flavoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016223:Flavoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.222: Proc Natl Acad Sci USA 88:77737777[Abstract] Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S 1994 Induction of calcium-dependent nitric oxide synthases by sex hormones. 

Phrase: "Proc Natl Acad Sci USA 88"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "77737777"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weiner CP,"

Phrase: "Lizasoain I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Baylis SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Knowles RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Charles IG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "Moncada S 1994 Induction of calcium-dependent nitric oxide synthases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205263:Induction [Functional Concept]
   739   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by sex hormones."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0036884:Sex Hormones [Hormone,Pharmacologic Substance]
   861   C0009253:Sex [Organism Function]
   861   C0019932:Hormones [Hormone]
   861   C0036864:Sex [Behavior]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]
   777 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.223: Proc Natl Acad Sci USA 91:52125216[Abstract] Kauser K, Sonnenberg D, Tse J, Rubanyi GM 1997 17beta-estradiol attenuates endotoxin-induced excessive nitric oxide production in ovariectomized rats in vivo. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "52125216"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kauser K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sonnenberg D,"

Phrase: "Tse J,"

Phrase: "Rubanyi GM 1997 17beta-estradiol"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0014912:17beta estradiol [Hormone,Pharmacologic Substance,Steroid]
           Estradiol
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "endotoxin-induced excessive nitric oxide production in ovariectomized rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033268:production [Occupational Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.224: Am J Physiol 273:H506H509 Binko J, Majewski H 1998 17-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. 

Phrase: "Am"

Phrase: "J Physiol 273"

Phrase: ":"

Phrase: "H506H509 Binko J,"

Phrase: "Majewski H 1998 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "reduces"

Phrase: "vasoconstriction in endothelium-denuded rat aortas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0042396:Vasoconstriction [Organ or Tissue Function]
   753   C3536904:Vasoconstriction [Organ or Tissue Function]

Phrase: "through inducible NOS."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.225: Am J Physiol 274:H853H859 Kauser K, Sonnenberg D, Diel P, Rubanyi GM 1998 Effect of 17beta-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. 

Phrase: "Am"

Phrase: "J Physiol 274"

Phrase: ":"

Phrase: "H853H859 Kauser K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Sonnenberg D,"

Phrase: "Diel P,"

Phrase: "Rubanyi GM 1998 Effect of 17beta-oestradiol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on cytokine-induced nitric oxide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   897   C1327413:cytokine production [Organism Function]
   804   C0033268:production [Occupational Activity]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "aorta."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003483:Aorta [Body Part, Organ, or Organ Component]
  1000   C1278934:Aorta [Body Part, Organ, or Organ Component]
Processing 00000000.tx.226: Br J Pharmacol 123:10891096[Abstract] Sandyc R 1996 Estrogens impact on cognitive functions in multiple sclerosis. 

Phrase: "Br J Pharmacol 123"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "10891096"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sandyc R 1996 Estrogens impact on cognitive functions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "in multiple sclerosis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0026769:Multiple Sclerosis [Disease or Syndrome]
  1000   C1417325:multiple sclerosis [Gene or Genome]
   861   C0036429:Sclerosis [Pathologic Function]
   861   C0439064:Multiple [Quantitative Concept]
   789 E C0334135:Sclerotic [Functional Concept]
Processing 00000000.tx.227: Int J Neurosci 86:2331[Medline] Simpkin JV, Green PS, Gridley KE 1997 A fundamental role for oestrogens in cognition and neuroprotection. 

Phrase: "Int J Neurosci 86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063789:INT [Organic Chemical]
   812   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "2331"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Simpkin JV,"

Phrase: "Green PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Gridley KE 1997 A fundamental role for oestrogens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "neuroprotection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598958:Neuroprotection [Cell Function]
Processing 00000000.tx.228: In: Brioni JD, Decker MV (eds) Pharmacological Treatment of Alzheimers Disease: Molecular and Neurobiological Foundations. 

Phrase: "In"

Phrase: ":"

Phrase: "Brioni JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Decker MV (eds) Pharmacological Treatment of Alzheimers Disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0013216:Pharmacological Treatment [Therapeutic or Preventive Procedure]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: ":"

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Neurobiological Foundations."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundations [Organization]
   768 E C0002055:base [Inorganic Chemical]
   768 E C0178499:Base [Chemical Viewed Functionally]
   768 E C1626935:Bases [Quantitative Concept]
   768 E C1880279:Base [Biomedical or Dental Material]
   750 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.229: John Wiley & Sons, New York Honjo H, Tanaka K, Kashiwagi T, Urabe M, Okada H, Hayashi M, Hayashi K 1995 Senile dementia of Alzheimers type and oestrogens. 

Phrase: "John Wiley & Sons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037683:Son [Family Group]

Phrase: "New York Honjo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kashiwagi T,"

Phrase: "Urabe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Okada H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hayashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hayashi K 1995 Senile dementia of Alzheimers type"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   789   C0877811:Dementia senile/Alzheimer [Disease or Syndrome]
   770   C0002395:Dementia, Senile [Disease or Syndrome]
           alzheimers dementia
   770   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0392079:Senile [Finding]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "oestrogens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014939:Oestrogens [Hormone,Pharmacologic Substance,Steroid]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.230: Horm Metab Res 27:204207[Medline] Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R 1996 Effect of oestrogens during menopause on risk and age at onset of Alzheimers disease. 

Phrase: "Horm Metab Res 27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "204207"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tang MX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]

Phrase: "Jacobs D,"

Phrase: "Stern Y,"

Phrase: "Marder K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Schofield P,"

Phrase: "Gurland B,"

Phrase: "Andrews H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mayeux R 1996 Effect of oestrogens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0877035:Oestrogen effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "during menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "age at onset of Alzheimers disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.231: Lancet 348:429433[CrossRef][Medline] Miller l, Alley EW, Murphy WJ, Russell SW, Hunt JS 1996 Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. 

Phrase: "Lancet 348"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "429433"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miller l,"

Phrase: "Alley EW,"

Phrase: "Murphy WJ,"

Phrase: "Russell SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Hunt JS 1996 Progesterone"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0033308:Progesterone [Hormone,Pharmacologic Substance,Steroid]
   812   C2757070:Progesterone [Pharmacologic Substance]
   756 E C0010094:Corpus luteum hormone [Hormone]
   756 E C0701112:Proluton [Hormone,Pharmacologic Substance,Steroid]
   756 E C0701115:Lutromone [Hormone,Pharmacologic Substance,Steroid]
   756 E C0701118:Lipo-Lutin [Hormone,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "inducible nitric oxide synthase gene expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   734   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "nitric oxide production in murine macrophages."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]
Processing 00000000.tx.232: J Leukoc Biol 59:442450[Abstract] Hayashi T, Yamada K, Esaki T, Muto E, Chaudhuri G, Iguchi A 1998 Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. 

Phrase: "J Leukoc Biol 59"

Phrase: ":"

Phrase: "442450"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hayashi T,"

Phrase: "Yamada K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Esaki T,"

Phrase: "Muto E,"

Phrase: "Chaudhuri G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Iguchi A 1998 Physiological concentrations of 17beta-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the synthesis of nitric oxide synthase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1157570:nitric oxide synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "in macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "via a receptor-mediated system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.233: J Cardiovasc Pharmacol 31:292298[CrossRef][Medline] Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hsieh CM, Kourembanas S, Lee ME 1994 Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. 

Phrase: "J Cardiovasc Pharmacol 31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "292298"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perrella MA,"

Phrase: "Yoshizumi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fen Z,"

Phrase: "Tsai JC,"

Phrase: "Hsieh CM,"

Phrase: "Kourembanas S,"

Phrase: "Lee"

Phrase: "ME 1994 Transforming growth factor-beta 1,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   947   C1366557:Transforming growth factor beta 1 [Gene or Genome]
   947   C1515406:Transforming Growth Factor-Beta 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   947   C1704256:Transforming Growth Factor Beta 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0330390:Beta [Plant]
   799   C0439096:Beta [Intellectual Product]
   799   C1510411:Transforming [Pathologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2004068:Beta [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "but"

Phrase: "not dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   805 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   805 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   805 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "nitric-oxide synthase mRNA after its induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0335218:Messenger [Professional or Occupational Group]

Phrase: "by interleukin-1 beta"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0021753:Interleukin-1 beta [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334112:INTERLEUKIN 1-BETA [Gene or Genome]
  1000   C1522432:interleukin-1-beta [Immunologic Factor,Pharmacologic Substance]
   901   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "in rat smooth muscle cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.234: J Biol Chem 269:1459514600[Abstract/Free FullText] Kunz D, Mhl H, Walker G, Pfeilschifter 1994 Two distinct signalling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1459514600"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kunz D,"

Phrase: "Mhl H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Walker G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Pfeilschifter 1994 Two distinct signalling pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   810   C0037080:Signal Pathways [Molecular Function]
   810   C0037083:signalling pathway [Cell Function]
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the expression of inducible nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat renal mesangial cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0227651:Renal Mesangial Cells [Cell]
           Mesangial Cells
   858   C0553257:Renal cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.235: Proc Natl Acad Sci USA 91:53875391[Abstract] Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "53875391"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mangelsdorf DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Thummel C,"

Phrase: "Beato M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Herrlich P,"

Phrase: "Schutz G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Umesono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Blumberg B,"

Phrase: "Kastner P,"

Phrase: "Mark M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chambon P,"

Phrase: "Evans RM 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2951520:RM [Body Location or Region]

Phrase: "The nuclear receptor superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883220:Superfamily [Conceptual Entity]
   734   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "the second decade."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2981279:Decade [Quantitative Concept]
Processing 00000000.tx.236: Cell 83:835839[Medline] Xie Q, Kashiwabara Y, Nathan C 1994 Role of transcription factor NF-B/Rel in induction of nitric oxide synthase. 

Phrase: "Cell 83"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "835839"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xie Q,"

Phrase: "Kashiwabara Y,"

Phrase: "Nathan C 1994 Role of transcription factor NF-B/Rel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of nitric oxide synthase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.237: J Biol Chem 269:47054708[Abstract/Free FullText] Kleinert H, Euchenhofer C, Ihrig-Biedert I, Frstermann U 1996 In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-B. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "47054708"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kleinert H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Euchenhofer C,"

Phrase: "Ihrig-Biedert I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Frstermann U 1996 In murine 3T3 fibroblasts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016030:Fibroblasts [Cell]
   748   C0026809:Murine [Mammal]
   748   C0591833:Murine [Organic Chemical,Pharmacologic Substance]

Phrase: "different second messenger pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0682673:second pathway [Body Part, Organ, or Organ Component]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "resulting in the induction of NO synthase II"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0132555:NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0332294:Resulting in [Functional Concept]
   744   C0205263:Induction [Functional Concept]
   744   C0678226:resulting [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "(iNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0669372:INOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:INOS [Gene or Genome]
  1000   C1968833:INOS [Gene or Genome]
  1000   C3539722:iNOS [Gene or Genome]

Phrase: ")"

Phrase: "converge in the activation of transcription factor NF-B."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   762   C0162493:Transcription Activation [Genetic Function]
   762   C1824728:FACTOR B [Gene or Genome]
   742   C0040649:Transcription [Genetic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1879547:Activation [Activity]
   742   C2700387:Converge [Activity]
   742   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.238: J Biol Chem 271:60396044[Abstract/Free FullText] Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S, Kishimoto T 1997 Characterisation of mechanisms of interleukin-6 gene repression by estrogen receptor. 

Phrase: "J Biol Chem 271"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "60396044"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kurebayashi S,"

Phrase: "Miyashita Y,"

Phrase: "Hirose T,"

Phrase: "Kasayama S,"

Phrase: "Akira S,"

Phrase: "Kishimoto T 1997 Characterisation of mechanisms of interleukin-6 gene repression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880022:Characterization [Activity]

Phrase: "by estrogen receptor."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.239: J Steroid Biochem Mol Biol 60:1117[CrossRef][Medline] Nathan C, Xie Q-W 1994 Regulation of biosynthesis of nitric oxide. 

Phrase: "J Steroid Biochem Mol Biol 60"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0027960:Mole [Neoplastic Process]
   799   C0038317:Steroid [Steroid]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1456781:mole [Neoplastic Process]
   799   C1824986:mol [Gene or Genome]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "1117"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nathan C,"

Phrase: "Xie Q-W 1994 Regulation of biosynthesis of nitric oxide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   815   C1157571:regulation of nitric oxide biosynthesis [Cell Function]
   782   C1157723:regulation of biosynthesis [Molecular Function]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.240: J Biol Chem 269:1372513728[Free FullText]

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1372513728"

Phrase: "[Free FullText"

Phrase: "]"

